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Abstract 
 
Overuse and misuse of antibiotics has led to the global spread of antimicrobial 
resistance, threatening our ability to treat bacterial infections. The horizontal 
acquisition of multidrug resistance (MDR) plasmids, from other bacterial 
lineages, has been instrumental in spreading resistance. Newly acquired 
plasmids are often poorly adapted to hosts causing intragenomic conflicts, 
reducing the competitiveness of plasmid-carrying strains. Costs can be 
overcome by positive selection for plasmid-encoded adaptive traits in the short-
term, or ameliorated by compensatory evolution in the long-term. How the 
selection and adaptation of MDR plasmids varies with antibiotic treatment 
remains unclear. First, I demonstrate that the selective conditions for the 
maintenance of an MDR plasmid are dependent upon the sociality of resistance 
it encodes. Selection for efflux of antibiotics, a selfish trait, occurred at very low 
concentrations of antibiotic, far below the minimum inhibitory concentration of 
sensitive plasmid-free strain. In contrast, selection for inactivation of antibiotics, 
a cooperative trait, increased the amount of antibiotic required to select for the 
MDR plasmid, allowing sensitive plasmid-free bacteria to survive high levels of 
antibiotic. These selection dynamics were only accurately predicted when 
mathematical models included the mechanistic details of antibiotic resistance. 
Secondly, I show that the trajectory of evolution following MDR plasmid 
acquisition varies with antibiotic treatment. Tetracycline treatment favoured a 
distinct coevolutionary trajectory of chromosomal resistance mutations coupled 
with plasmid mutations impairing plasmid-borne resistance. This led to high-
level, low-cost antibiotic resistance, but also produced an integrated genome of 
co-dependent replicons that may limit the onward spread of co-adapted MGEs 
to other lineages. This evolutionary trajectory was strikingly repeatable across 
independently evolving populations despite the emergence of multiple 
competing lineages within populations. The results presented here demonstrate 
that the interaction between positive selection and compensatory evolution can 
help to explain the persistence of MDR plasmids in the clinic and the 
environment. 
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1. Introduction 
 
Antibiotics are one of the greatest tools of modern medicine; their routine use as 
a first line therapy for bacterial infections, as well as prophylactic use during 
chemotherapy and invasive operations to prevent infection, has significantly 
reduced mortality and increase life expectancy. However, the emergence of 
antimicrobial resistant (AMR) bacteria, particularly those with multi-drug 
resistance (MDR), is a major risk to global health, as the drugs which we are 
dependent on diminish in effectiveness (World Health Organization, 2015). Over 
2 million people are estimated to become infected with AMR infections each 
year in the US alone, 23,000 of whom die (CDC, 2013). In the EU 25,000 
patients die each year of infections caused by AMR bacterial (EMEA and ECDC, 
2009). The limited pace of novel antibiotic discovery is overshadowed by the 
ever increasing spread of AMR (Lewis, 2013). A recent UK review predicts 10 
million deaths per-year will be attributable to AMR infections globally by 2050 if 
current trends in the spread of AMR are not tackled (O’Neill, 2014). The 
horizontal gene transfer (HGT) of resistance genes across lineages, species 
and families of bacteria is a key driver in the global spread of AMR (Maiden, 
1998). These resistance genes often cluster upon semi-autonomous mobile 
genetic elements (MGEs), such as conjugative plasmids, which allow the 
instantaneous acquisition of multiple resistance genes in a single event, 
increasing the emergence of MDR bacterial pathogens (Carattoli, 2013). The 
spread of AMR through the exchange of plasmids remains one of the most 
difficult challenges in the fight against resistance. Therefore understanding the 
selection and evolution of plasmid borne resistance is critical in dealing with this 
challenge. 
 
This thesis aims to add to our current understanding of plasmid borne AMR by 
examining the how selection for MDR plasmids varies with the mode of antibiotic 
resistance, and how plasmids and bacterial hosts evolve under different 
antibiotic treatments. This introductory chapter will briefly introduce the global 
emergence of AMR along with the core themes of the thesis, namely plasmids 
as vessels of AMR, the costs and sociality of antibiotic resistances, and 
evolution of plasmids and their bacterial hosts. 
 
 
	 11 
1.1 Emergence of Antimicrobial Resistance 	
1.1.1 Discovery 
Alexander Fleming famously discovered the first antibiotic, penicillin, by accident 
in 1928 when he observed zones of clearing around a Penicillium fungus that 
was contaminating an agar plate of staphylococci. The ease with which bacteria 
could evolve resistance to penicillin was soon noted, and referred to in 
Fleming’s acceptance speech for The 1945 Nobel Prize in Physiology or 
Medicine, awarded for the discovery of penicillin:  
 
 “It is not difficult to make microbes resistant to penicillin in the laboratory 
by exposing them to concentrations not sufficient to kill them” – Alexander 
Fleming (1945) 
 
However, at this time resistance was not of major concern, because the rate of 
antibiotic discovery for the following 40 years was sufficient to outpace the 
spread of resistance. This was, in part, thanks to a discovery platform 
introduced by Selman Waksman in the early 1940’s. Waksman’s screening for 
antimicrobial compounds from soil microbes, notably streptomycetes, led to the 
discovery of streptomycin, the first aminoglycoside antibiotic, and paved the way 
for systematic screening for novel antimicrobial compounds (Schatz et al., 
1944). The cheap and efficient screening method of searching for zones of 
inhibition in lawns of bacteria on agar plates established by Fleming and 
Waksman led to an antibiotic discovery boom throughout the 50’s and 60’s 
(Figure 1.1). Approximately two thirds of naturally derived antibiotics have been 
isolated from soil actinomycetes (Fair and Tor, 2014). However, systematic 
screening for novel classes of antibiotic tailed off as the rate of discovery of new 
antibiotics by this method declined (Lewis, 2013).  
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Figure 1.1 | The Antibiotic Timeline. The dates of discovery, introduction, and 
first observation of resistance of major classes of antibiotics. Data source: Lewis 
(2013). 
 
 
1.1.2 The antibiotic discovery void 
As rates of novel antibiotic discovery from natural products diminished, a greater 
emprises on targeted drug design and synthesis was adopted in a bid to reduce 
rediscovery and cross-resistance rates (Silver, 2011). Optimisation of natural 
products showed some success, increasing the spectrum and stability of 
compounds while avoiding the action of specific resistance mechanisms, with 
the development of semi-synthetic β-lactam’s as a prime example (Elander, 
2003). However, the synthetic production of antibiotics was less than fruitful 
(Fair and Tor, 2014), with no new classes of antibiotic being discovered between 
1987 and 2015 (Ling et al., 2015; Silver, 2011). The combination of decreasing 
success rates of discovery and declining profitability of antibiotic production, 
together with difficulties in novel drug approval, led many big pharmaceutical 
companies to abandon their antibiotic discovery programs in the late 1990s 
(Projan, 2003). As a result, this has placed greater pressure on the remaining 
antibiotics we have at our disposal. Exacerbating this problem, global usage of 
antibiotics has increased by 36% from 2000 to 2010 (Boeckel et al., 2014), with 
use of ‘last-resort’ antibiotics, such as vancomycin, becoming more common. 
Increased use, coupled with the stagnation of antibiotic discovery, is a major 
threat to public heath as antibiotic resistance spreads rapidly across the globe.  
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This global spread of AMR is due to the evolution of resistant genotypes via de 
novo mutation or acquisition of novel resistance genes via HGT (section 1.2) 
which then increase in frequency due to positive selection arising from antibiotic 
usage. Resistant strains spread within local clinical settings from patient to 
patient, nationally between clinics though the movement of patients and 
healthcare workers, and internationally through global travel networks. For 
example, methicillin-resistant Staphylococcus aureus (MRSA), first observed in 
the UK in the early 1990’s, rose from 2% to 40% of S. aureus infections within 
the UK within 8 years (Johnson et al., 2001). MRSA has since spread globally, 
being observed within Europe, Australia and Singapore (Holden et al., 2013). 
Similarly, the resistance enzyme New Delhi metallo-β-lactamase (NDM), first 
observed within a bacterial pathogen in 2008, has spread to over 40 counties 
due to both the spread of pandemic bacteria, and inter-species and inter-genus 
transmission of blaNDM containing MGEs (section 1.2) (Johnson and Woodford, 
2013).  
 
1.1.3 Appearance of resistance in bacteria 
Bacteria can be intrinsically resistant to specific classes of antibiotic due to the 
functional or structural characteristics of the cell, for example certain classes of 
antibiotic cannot permeate the gram-negative cell membrane, or specific 
antibiotic targets may be missing from certain bacterial taxa (Blair et al., 2015). 
This limits the choice of affective antibiotics but does not contribute to the 
spread of resistance. Alternatively, bacteria can gain resistance to antibiotics, 
either through de novo mutation or HGT of antimicrobial resistance genes 
(ARGs). De novo mutations typically enhance resistance in 3 ways: they may 
lead to changes in the structure of the antibiotic target to decrease the 
antibiotic’s binding affinity (Rybkine et al., 1998), increase the expression of 
efflux machinery to remove antibiotic from the cell, or cause reduced membrane 
permeability to limit access of the antibiotic to the target (Guay et al., 1994; 
Phan and Ferenci, 2017; Webber and Piddock, 2001). De novo resistance 
mutations are typically vertically inherited (i.e. passed on through cell division) 
and therefore largely remain clonal, and are commonly observed in chronic 
bacterial infections (Oliver et al., 2000). By contrast, horizontally acquired ARGs 
can be shared among distantly related bacteria and come pre-packaged upon 
MGEs. Commonly horizontally acquired resistance mechanisms include new 
efflux systems, enzymes that modify or inactivate the antibiotic, or alternative 
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genes that can replace the function of the antibiotic target without being inhibited 
by the antibiotic (Cantón and Coque, 2006; Popowska and Krawczyk-Balska, 
2013). ARGs carried on MGEs can be both vertically inherited, or transferred 
horizontally between cells. 
 
Horizontally acquired resistance mechanisms are often sophisticated 
specialised molecules begging the question: where did these resistance 
mechanisms come from to begin with? The evolution of antibiotic resistance can 
be split into pre- and post-antibiotic eras denoting the periods before and after 
the clinical use of antibiotics (Aminov, 2009). Antibiotic resistance predates 
clinical use of antibiotics, with evidence of diversification and selection of ARGs 
in natural bacterial communities from 30,000 year old permafrost samples 
(D’Costa et al., 2011) and a four million year old cave system (Bhullar et al., 
2012). Phylogenetic evidence supports this ancient evolution of ARGs, with the 
enzyme β-lactamase, a resistance mechanism to the most widely used 
antibiotics, β-lactams, predicted to have originated over two billion years ago 
(Hall et al., 2004). This ancient history of resistance is coupled with the fact that 
most of the antibiotics we use are derived from natural microbial products, 
produced by fungi and bacteria. In natural communities, antibiotics are excreted 
into the local environment by microbes to inhibit growth of neighbouring 
bacteria, providing a competitive advantage to the antibiotic producing 
population. ARGs are likely to have originally evolved to protect antibiotic 
producers from their own weapons or as defence mechanisms in the targeted 
organisms.  
 
Interestingly, some authors have suggested that natural concentrations of 
antimicrobial compounds found within environments, not affected by 
anthropogenic contamination, are often too low to exert lethal effects on bacteria 
(Aminov, 2009). It has therefore been proposed that these compounds could 
play a role in cell-to-cell communication, signalling, and gene regulation in 
bacterial communities (Aminov, 2009). Sub-inhibitory concentrations of 
antibiotics have been shown to induce biofilm formation (Linares et al., 2006), 
and influence quorum sensing within bacterial populations (the process of 
altering gene expression in response to cell density) (Thomson et al., 2000). 
The role of antibiotics beyond a form of bacterial chemical warfare remains 
incomplete, however it is clear that these molecules have wider implications 
than merely inhibitory action. 
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The use of antibiotics over the last century can be thought of as an evolution 
experiment on a global scale (Andersson and Levin, 1999). The anthropogenic 
use of antibiotics during the post-antibiotic era has placed incredibly strong 
selection pressures upon bacteria to gain resistance across all ecosystems. 
ARGs that happen to provide resistance, which once may have been involved 
with other metabolic functions, have been mobilised from the gene pool of 
natural communities and have spread rapidly within pathogenic and commensal 
bacteria (Wright, 2010). ARGs can now provide a huge competitive advantage, 
increasing growth rates and decreasing mortality when under antibiotic 
selection. The selection and spread of antibiotic resistance has proceeded 
within a very short evolutionary time scale, less than a century, during which 
HGT mediated by MGEs has played a prominent role.  
 
 
1.2 The Horizontal Transfer of Antimicrobial Resistance 
 
HGT occurs extensively among prokaryotes, with large proportions of bacterial 
genomes consisting of horizontally acquired accessory genes (Young, 2016). 
The acquisition of genetic material from different lineages via the transfer of 
MGEs is a fundamental driver of bacterial adaptation and diversification, 
allowing the sharing of ecologically important genes between distantly related 
bacteria (Jain et al., 2003; Wiedenbeck and Cohan, 2011). These non-essential 
accessory genes provide traits, in addition to house-keeping functions present in 
the core genome, accelerating adaption to novel or fluctuating environments by 
bypassing the requirement for rare de novo mutations (Frost et al., 2005; 
Norman et al., 2009), and thus permitting bacteria to occupy ecological niches 
which were previously inaccessible. This communal gene pool of MGEs can be 
transferred between bacteria in three prominent ways: transformation, 
transduction and conjugation (Figure 1.2). Plasmids are the primary conjugative 
MGEs, and are the principle cause of MDR phenotypes within both clinical and 
commensal bacteria (Bennett, 2008). 
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Figure 1.2 | Mechanisms of horizontal gene transfer between bacteria. Genetic 
material can transfer between bacteria in three main ways: 1) Transduction – 
bacterial DNA can be mistakenly packaged within phage (viruses that infect 
bacteria), and transferred into new hosts during infection.  2) Transformation – 
DNA from the environment, often released upon cell death, can be taken up by 
some species of bacteria. 3) Conjugation – the process by which mobile genetic 
elements are transferred from a donor bacterium to a recipient bacterium, 
bacteria are drawn together by a pilus produced by the donor cell to form a 
mating pair, at which point the mobile genetic element is copied into the new 
host. Extra-chromosomal plasmids and genomic integrative and conjugative 
elements (ICE) are often transferred in this way. Adapted from Holmes et al. 
(2016). 
 
1.2.1 Bacterial plasmids 
Conjugative plasmids are semi-autonomous MGEs that act as shuttles for the 
transfer of genes between bacterial lineages (Bergstrom et al., 2000). The most 
common structure of plasmids are closed circular double stranded DNA 
molecules, and the defining feature of plasmids is that their replication is 
independent of the host chromosome. This independence allows them to be 
horizontally transmitted between distantly related bacteria through conjugation, 
making them a major contributor to the communal gene pool (Norman et al., 
Conjugation
Transduction
Transformation
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2009). Independence from the host chromosome also potentially decouples the 
evolutionary pressures acting upon plasmids and the host, resulting in plasmids 
having and pursuing their own evolutionary interests subject to distinct selective 
pressures. Consequently, the fitness of plasmids may not be aligned to that of 
their hosts, allowing for both conflict and cooperation between plasmid and host 
contingent upon the prevailing environment (Harrison and Brockhurst, 2012; 
MacLean and San Millan, 2015). This broad array of interactions generates 
reciprocal selection and adaptation, shaping structure and function of both 
plasmid and chromosomal replicons. 
 
1.2.2 Plasmid structure 
Plasmids are modular in structure, with genes of similar function clustered 
together into discrete regions of the molecule. This mosaic structure of genes 
and operons from different sources is the result of frequent recombination 
events, such as the acquisition of transposable elements (Norman et al., 2009). 
Plasmids can therefore be partitioned into the core ‘backbone’ of genes that 
encode plasmid-specific functions, and ‘accessory’ elements that are not 
required by the plasmid. The backbone genes can broadly be split into three 
functional groups controlling replication, stability, and conjugation. These 
plasmid-specific functions are not essential to the bacterial host; making these 
parts of the plasmid sequence dispensable from the viewpoint of the bacteria.  
 
The defining feature of a plasmid is the replication (rep) system. This system 
generally requires a plasmid encoded initiator protein that binds on the plasmid’s 
origin of replication (oriV) before the recruitment of the host’s DNA replication 
machinery (DNA helicases, DNA polymerase, DNA clamp, topoisomerase etc.) 
(Solar et al., 1998). The plasmid’s rep system is often coupled with modules 
(cop) that activate or inhibit the expression of the rep proteins, hence control the 
copy number of the plasmid. The rep system also defines the incompatibility 
group of a plasmid as multiple plasmids with similar rep systems interfere with 
each other’s copy number, preventing similar plasmids from occupying the same 
host (Carattoli et al., 2005). 
 
The host range of a plasmid is usually limited by the compatibility of the rep 
system with the hosts DNA replication machinery (Zhong et al., 2005). Some 
plasmids can only be stably maintained within only narrow range of hosts, such 
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as Inc-F or IncI group which are only found within Enterobacteriaceae (Carattoli, 
2009). In contrast, broad-host-range plasmids, such as the members of the 
IncP-1 family, can transfer and propagate within almost all gram-negative 
bacteria, thanks to their control systems, multiple rep initiation proteins and 
stability systems (Fang and Helinski, 1991; Popowska and Krawczyk-Balska, 
2013). These plasmids have a wide environmental distribution, present in soils, 
wastewater, livestock manure and river sediment (Bahl et al., 2007; Sen et al., 
2011, 2013; Szczepanowski et al., 2009).  
 
The maintenance of a stable plasmid copy number within a host is vital to a 
plasmid’s survival. If the copy number were to raise too high, the metabolic 
burden of the plasmid upon the host would be unsustainable (Norman et al., 
2009) whereas if copy number drops too low, the plasmids could be lost at cell 
division (a process called segregation). As plasmid-free segregants have the 
competitive advantage of not incurring the metabolic cost of plasmid 
maintenance (section 1.3), appreciable rates of segregational loss of a plasmid 
could rapidly lead to the plasmid’s extinction. Small plasmids often rely on high 
copy numbers and diffusion to ensure plasmids are present in both mother and 
daughter cells (Summers and Sherratt, 1984). However, when the copy number 
of a plasmid drops below ~10 per cell a more active approach to maintaining 
plasmids over many generations is required (Thomas, 2000). This comes in the 
form of plasmid encoded stability modules, which ensure the plasmid is 
maintained in both daughters at cell division. Plasmid active partitioning systems 
encode actin like filaments that push the plasmids to the opposite poles of a 
dividing cell (Salje et al., 2010), allowing stable inheritance. Many plasmids also 
carry post-segregational killing (also known as addiction) systems that kill any 
plasmid free segregants that may arise. These generally consist of toxin-
antitoxin (TA) systems comprising a stable toxin and an unstable antitoxin; upon 
plasmid loss the antitoxin degrades faster than the toxin, leaving sufficient toxin 
remaining to kill any plasmid free cells (Jensen and Gerdes, 1995). 
 
The conjugation modules of a plasmid allow its transfer horizontally from cell-to-
cell. Self-propagating conjugative plasmids encode genes for mate pair 
formation, the physical linkage of two cells via the formation of a conjugation 
pilus. A second DNA processing step is required to generate the single stranded 
DNA molecule, propagate its transfer via the pilus and synthesise the second 
strand in the donor and recipient (Norman et al., 2009). Mobilizable plasmids do 
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not encode the genes required for mate pair formation and only harbour the 
DNA processing genes, hitchhiking on the pili formed by cohabiting conjugative 
plasmids.  
 
Plasmids may also carry accessory genes that impart adaptive traits on their 
hosts, but are not essential for the maintenance of the plasmid (Rankin et al., 
2011). These accessory genes are themselves often carried upon MGEs, such 
as transposons, nested within the plasmid resembling a Russian doll-like 
architecture (Sheppard et al., 2016). The separate origin of accessory genes is 
also evidenced by the fact that their GC content is often different from the 
plasmid backbone (Norman et al., 2009). The mobility of accessory genes 
allows for their transposition both between plasmids and onto the chromosomes 
of their hosts (Hall et al., 2017a; Sheppard et al., 2016). Accessory genes 
encode a wide range of adaptive traits including virulence factors (Johnson and 
Nolan, 2009), novel metabolic functions (Sen et al., 2011; Young et al., 2006) 
and resistance to heavy metals or antimicrobials (Baker-Austin et al., 2006; 
Bennett, 2008).  The benefits of accessory traits are usually ecologically 
contingent, only increasing bacterial fitness within specific environments. As 
such, these traits often allow bacteria to exploit novel niches, such as eukaryotic 
hosts or contaminated environments (Nogueira et al., 2009; Ramírez-Díaz et al., 
2011; Schwarz and Johnson, 2016). It has been noted that many of the adaptive 
traits encoded by plasmids have social effects within microbial communities, 
with accessory gene products affecting not only the host, but the fitness of 
neighbouring cells as well (Rankin et al., 2011). 
 
1.2.3 Plasmid prevalence and the spread of AMR 
Plasmids play a prominent role in the spread of AMR, with plasmid-conferred 
resistance encompassing nearly all currently used antibiotics (Bennett, 2008). 
The dissemination of resistance plasmids has led to a number of global 
resistance pandemics, with plasmids promoting the spread of the CTX-M 
extended spectrum β-lactamases (ESBL) (Cantón and Coque, 2006; Dhanji et 
al., 2011), carbapenemases (Déraspe et al., 2014), and quinolone resistances 
(Rodríguez-Martínez et al., 2011). Of particular concern are plasmids which 
contain multiple ARGs providing resistance to different antibiotics, so called 
MDR plasmids (Popowska and Krawczyk-Balska, 2013), which offer bacteria 
with resistance to multiple antibiotics in a single step and thus potentiate the 
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rapid emergence of MDR phenotypes in bacterial pathogens (Norman et al., 
2008; Wright, 2010). To understand the maintenance, enrichment, and 
transmission of antibiotic resistance plasmids, extensive work has been 
conducted exploring the fitness cost, selection and evolution of plasmid borne 
AMR, which will be discussed in the following sections.  
 
 
1.3 The Cost of Plasmid Carriage 
 
Although ecologically important accessory traits encoded upon plasmids can 
provide benefits to their bacterial hosts, plasmids often reduce the competitive 
fitness of bacteria in the absence of positive selection (Baltrus, 2013). These 
fitness costs can result in strong purifying selection against plasmid carriage, as 
plasmid-free bacteria may have higher growth rates, sorter lag times, or higher 
population densities than isogenic plasmid-containing bacteria (Andersson and 
Hughes, 2010). As a result, the fitness cost of plasmid carriage can impede the 
maintenance of plasmids within bacterial populations. Costs associated with 
plasmid carriage, originally coined metabolic burden in recombinant bacteria, 
have long been observed (Bentley et al., 1990), but recent studies utilising 
whole genome sequencing and transcriptomics have expanded our 
understanding of the basis of plasmid costs (Harrison et al., 2015; Loftie-Eaton 
et al., 2017; Porse et al., 2016; San Millan et al., 2015; Yano et al., 2016). The 
physiological costs induced by plasmids can generally be categorised as either 
direct metabolic costs, due to increased transcription and translation associated 
with the expression of plasmid-encoded genes, or indirect, through the 
disruption of cellular networks. The causes of fitness costs associated with 
plasmid carriage are not mutually exclusive; multiple interacting effects are likely 
to give rise to the physiological costs plasmids impose on their hosts. 
 
1.3.1 Metabolic costs of plasmid carriage 
The metabolic costs of plasmid carriage stem from the increase in genetic 
material within the cell. The maintenance and replication of extra DNA is unlikely 
to cause significant direct costs, as the relative quantity of DNA within the cell 
tends not to increase significantly upon plasmid acquisition (Baltrus, 2013; San 
Millan and MacLean, 2017). Rather, costs are associated with the expression of 
novel genes introduced by the plasmid. The transcription of the newly acquired 
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plasmid genes is not thought to incur a significant cost (San Millan and 
MacLean, 2017). However, as the levels of expression of horizontally acquired 
genes are generally unoptimised (Park and Zhang, 2012), high levels of 
expression of plasmid encoded genes increases the translational load of the 
cell, and is expected to be the major source of cost during gene expression 
(Baltrus, 2013; Glick, 1995; San Millan and MacLean, 2017). The increase in 
cellular mRNA places a burden upon ribosomes which are occupied during 
translation at the expense of translation of host encoded genes (Shachrai et al., 
2010). An increase in translation can also cause costs to arise due to increased 
consumption of limited amino acids, starving the cells of this essential resource 
and slowing down growth rates (Glick, 1995; Shachrai et al., 2010). Another 
source of cost during translation arises due to significant differences in codon 
usage between the plasmid genes and the host cell. These differences lead to a 
reduction in translation efficiency, affecting the speed and accuracy of 
translation (Plotkin and Kudla, 2011). This in turn can lead to the stalling of 
translation, mRNA degradation before translation, errors in the protein sequence 
and protein misfolding, all of which are costly (Drummond and Wilke, 2008).  
 
1.3.2 Disruption of cellular networks 
As well as the metabolic costs of plasmid carriage, cellular networks can also be 
disrupted at the cost of host fitness. The increased transcriptional load induced 
by the acquisition of a plasmid can trigger a potentially disproportional global 
transcriptional response, perturbing the level of expression of large numbers of 
chromosomal genes, particularly those involved with translation (Harrison et al., 
2015; San Millan et al., 2015). The host SOS stress response can also be 
triggered for a number of reasons upon acquisition of a conjugative plasmid. 
The SOS response is usually triggered by DNA damage and is responsible for 
DNA repair; however, the triggering of this complex host network also increases 
mutagenesis, stalls chromosomal replication and suppresses cell division, 
reducing the cells competitive fitness (D’Ari and Huisman, 1983; Kawai et al., 
2003). Conjugation introduces single stranded plasmid DNA (ssDNA) into a 
novel host cell, triggering the host SOS stress response (Baharoglu et al., 
2010). This potentially limits the potential success of horizontal transfer as some 
conjugative plasmids encode genes that act to alleviated the SOS stress 
response during conjugation (Althorpe et al., 1999). Plasmid rep systems can 
also trigger the SOS response by sequestering the chromosomal replication 
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machinery through the recruitment of host DNA replication proteins (Ingmer et 
al., 2001; Loftie-Eaton et al., 2017; San Millan et al., 2015).   
 
The costs that plasmids impose on their hosts are a critical driver of the 
evolution of plasmid borne AMR. These fitness effects can be a major limitation 
to the success of both horizontal and vertical transmission of the MGEs, 
determining under which environments the MGE is beneficial (Bergstrom et al., 
2000). Plasmid costs can also drive the adaptation of both host and 
chromosomal genes, as costs can lead to evolution of strains that have 
ameliorated the costs of plasmid carriage (Harrison and Brockhurst, 2012).  
 
 
1.4 Selection of Plasmid Borne Resistance 
 
The aim of clinical antibiotic use is to provide sufficient antibiotic so that 
infections are cleared while minimising the toxic side effects inherent to many 
classes of antibiotics. Laboratory determination of the lowest concentration at 
which a drug inhibits all growth of bacteria, the minimal inhibitory concentration 
(MIC), is a key tool in predicting clinical antibiotic dosage. The traditional view is 
that resistance is selected for at concentrations of antibiotic above the MIC of 
sensitive strains despite the costs associated with resistance (Andersson, 2006; 
Drlica, 2003), as high concentrations of antibiotics select for resistance at the 
complete exclusion of sensitive strains. However, antibiotic gradients ranging 
from well in excess of the MIC, to far bellow the MIC (sub-MIC) exist in humans, 
livestock and the environment (Berendonk et al., 2015). In fact, far more 
environments contain concentrations of antibiotic below the MIC of sensitive 
cells than above (Kümmerer, 2003). The significance of antibiotics at sub-MIC 
levels upon the selection and maintenance of resistance has only recently been 
considered (Andersson and Hughes, 2014). Sub-MIC concentrations of 
antibiotics still reduce the growth of sensitive strains; if the reduction in growth 
outweighs the cost of resistance, resistance can be selected for below the MIC 
(Hughes and Andersson, 2012). However, the social interactions between 
bacteria can alter the outcome of antibiotic treatment, confounding sub-MIC 
selection dynamics. Processes, such as biofilm formation and cooperative 
resistance mechanisms, allow a population of bacteria to survive antibiotic 
treatment where a single cell would not (Vega and Gore, 2014). Moreover, these 
	 23 
social traits are often encoded as accessories genes upon plasmids (Rankin et 
al., 2011). Therefore, it is likely that the selection of antibiotic resistance 
plasmids depends on two factors: 1) the cost of plasmid carriage, and 2) the 
sociality of the traits that are being selected for.  
 
1.4.1 Sub-MIC selection of resistance 
Direct competition between antibiotic resistant and antibiotic sensitive strains is 
commonly used to determine at what drug concentration the growth is equal 
between the two strains. At this concentration of antibiotic resistance begins to 
be selected for and is defined as the minimum selectable concentration (MSC, 
Figure 1.3) (Gullberg et al., 2011). Enrichment of pre-existing resistance at sub-
MIC levels of antibiotic has been demonstrated empirically in a number of 
studies (Gullberg et al., 2011, 2014; Liu et al., 2011). These studies have shown 
that the MSC value of a resistance varies depending on the resistance under 
selection. Liu et al. (2011) demonstrated that the MSC for ciprofloxacin and 
tetracycline resistance encoded upon the Tn10 transposon within Escherichia 
coli was 1/5 and 1/20 of the MIC of the susceptible strain, respectively. Gullberg 
et al. (2011) obtained similar results; the MSC values for various resistances to 
tetracycline, ciprofloxacin and streptomycin were between 10-fold and 230-fold 
lower than the MIC of the susceptible strain in both E. coli and Salmonella 
enterica (Var, Typhimurium LT2). Interestingly, different mutations conferring 
resistance to the same antibiotic also displayed different MSC values. The MSC 
depended upon the cost of resistance, such that a lower cost resistance 
mutation had a lower MSC (Gullberg et al., 2011). The group went on to show 
that the concentrations of antibiotics (tetracycline, erythromycin, trimethoprim 
and kanamycin) and heavy metals (arsenite and copper) selecting for a costly 
MDR plasmid were, in all cases, lower than the MIC of the plasmid-free 
susceptible strain (Gullberg et al., 2014). The studies showed that very low 
concentrations of antibiotics that are often present in contaminated natural 
environments or in patients under antibiotic treatment are able to select for and 
maintain resistance. 
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Figure 1.3 | The selective windows of antimicrobial resistance. Under no 
antibiotic selection or extremely low concentrations of antibiotic, the susceptible 
strain (blue line) outcompetes the resistant strain (purple line) due to the fitness 
costs associated with resistance. Conventionally resistance was thought to be 
selected at concentrations of antibiotic between the minimum inhibitory 
concentration of the susceptible strain (MICSUSC) and minimum inhibitory 
concentration of the resistant strain (MICRES). However, sub-inhibitory 
concentrations of antibiotic insufficient to kill sensitive bacteria can selected for 
resistance past the minimum selectable concentration (MSC), i.e. the intersect 
of susceptible and resistance growth. Adapted from Gullberg et al. (2011). 
 
 
1.4.2 The sociality of antimicrobial resistance  
It is becoming increasingly evident that the social dynamics imparted by 
qualitatively different mechanisms of antibiotic resistance can alter the outcome 
of antibiotic treatment (Vega and Gore, 2014; Yurtsev et al., 2013). As a 
consequence, determining the MSC of resistances may not simply be a function 
of cost, but may also be determined by the sociality of resistance. Cooperative 
drug resistances such as the inactivation of antibiotics, provide a benefit to 
surrounding bacteria regardless of their resistance phenotype, and determine 
the prevalence of resistance genes within a population (Yurtsev et al., 2013).  
 
The enzymatic inactivation of antibiotics by resistant bacteria lowers the 
environmental concentration of antibiotics, allowing sensitive cells to survive and 
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compete under antibiotic treatment (Brook, 2009). Experimental systems have 
shown that the cooperative intracellular inactivation of chloramphenicol, via a 
plasmid borne acetyltransferase, allows the survival of sensitive strains through 
the detoxification of the environment in liquid culture, on semi-solid surfaces and 
in an in vivo mouse model (Sorg et al., 2016).  The enzymatic inactivation of β-
lactam antibiotics via β-lactamase also allows sensitive cells to survive initial 
concentrations of antibiotic that would usually kill them (Dugatkin et al., 2005; 
Medaney et al., 2016; Perlin et al., 2009; Yurtsev et al., 2013). When 
cooperative resistance carries a cost, whether due to the production of enzymes 
or due to resistance being encoded upon a plasmid, sensitive strains will grow 
faster than resistant strains once the antibiotic is cleared from the environment 
(Yurtsev et al., 2013). Therefore, the protection offered by cooperative 
resistances would be expected to push the MSC to higher values, with the 
precise extent of this effect dependent upon the cost of resistance. 
 
The selection of antibiotic resistance will depend therefore both on the cost and 
the sociality of resistance. Sub-MIC selection of resistance mechanisms would 
be expected for selfish resistance mechanisms that do not impart a social 
benefit upon surrounding sensitive cells. In contrast, cooperative resistance 
should be selected for at higher relative concentrations of antibiotic (i.e. higher 
fraction of the sensitive MIC). Multiple mechanistically different resistances are 
frequently clustered together onto conjugative plasmids (Carattoli, 2013). An 
outstanding question is how combinatorial antibiotic usage selects for MDR 
plasmids, especially for combinations of antibiotics requiring qualitatively 
different mechanisms of drug resistance. 
 
 
1.5 Amelioration of Plasmid Cost  
  
1.5.1 The plasmid paradox 
Conjugative plasmids are fundamental in the adaptation of bacteria, providing a 
source of novel genetic material, as well as acting as catalysts for evolutionary 
change (Frost et al., 2005). However, the existence of conjugative plasmids 
presents a paradox (Harrison and Brockhurst, 2012). The acquisition of a 
plasmid imparts a significant fitness cost upon the new host (section 1.3). 
Plasmid-free competitors will outcompete plasmid-containing bacteria, driving 
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the plasmid to extinction (Hall et al., 2016). Despite this plasmids remain 
widespread in bacteria. 
 
There are evolutionary processes and plasmid encoded mechanisms that may 
help to explain the maintenance of plasmids within bacterial populations. When 
the accessory traits are under positive selection, the plasmid can be stabilised in 
the short-term (section 1.4). However, if the accessory trait is mobilised on to 
the chromosome the plasmid becomes redundant, once again exposing the host 
to the unneeded costs of plasmid carriage, and thus the plasmid can be lost 
(Harrison and Brockhurst, 2012). Segregational loss of plasmids can be 
minimised by plasmid encoded stability systems such as active partitioning 
systems and TA modules (section 1.2.2). These help to stabilise plasmids by 
reducing the number of plasmid-free competitors (Loftie-Eaton et al., 2016). 
However, active partitioning systems are not perfect and anti-toxins can be 
transferred on the chromosome (Ramisetty and Santhosh, 2016), leading to the 
emergence of plasmid-free cells that will outcompete the plasmid-harbouring 
population.   
 
There are two main routes that can resolve the plasmid paradox and explain the 
stable existence of plasmids over the long-term – horizontal transfer and 
compensatory evolution. If infectious transfer rates of the plasmid between 
bacteria were high enough plasmids could survive within a population purely as 
a parasite, despite of the costs associated with them. However, the costs 
associated with conjugation are significant both for the host and recipient cells, 
the production of the conjugative pilus not only consumes host resources but 
opens the cell to attack from phage (Lin et al., 2011), and newly acquired 
ssDNA can trigger stress responses in novel hosts (section 1.3). Yet, several 
studies have shown that conjugative plasmids can have sufficient conjugation 
rates to allow them to invade and persist within bacterial populations (Hall et al., 
2016; Stevenson et al., 2017). However, modelling has suggested that due to 
the costs associated with elevated conjugation rates, amelioration of plasmid 
cost is a more likely long-term solution to stabilising the maintenance of 
plasmids (Hall et al., 2017b).  
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1.5.2 Evolution and Amelioration of Plasmid Cost 
Compensatory evolution can stabilise plasmids by reducing the cost of plasmid 
carriage. A number of long-term evolution experiments have demonstrated the 
ability of compensatory evolution to stabilise plasmids through adaptation of the 
host, plasmid or reciprocal coadaptation of both, reducing the fitness cost 
imposed by the plasmid (Dahlberg and Chao, 2003; Harrison et al., 2015; Loftie-
Eaton et al., 2016, 2017; Porse et al., 2016; San Millan et al., 2015; Sota et al., 
2010). The reduction in cost stabilises the plasmid within bacterial populations 
by reducing the purifying selection acting against it. 
 
1.5.2.1 Host adaptation 
Host compensatory adaptation of plasmid cost can resolve perturbed cellular 
homeostasis. Harrison et al. (2015) found that the acquisition of a large 
conjugative plasmid by Pseudomonas fluorescens SBW25 increased the 
expression of approximately 17% of the genome, including genes involved with 
protein synthesis, suggesting the plasmid incurred a high translational burden. A 
highly parallel and repeatable mutation arose within a chromosomal GacA/GacS 
global regulatory system, independent of whether the plasmid was under 
positive selection or not. The adaptation of the GacA/GacS system restored 
chromosomal expression to ancestral plasmid-free levels, and also down-
regulated the expression of plasmid genes. These results align closely to a 
similar study examining the amelioration of the cost of a small, non-transmittable 
antibiotic resistance plasmid within Pseudomonas aeruginosa PAO1 (San Millan 
et al., 2015). Again, the acquisition of the plasmid significantly altered the 
expression of a large proportion of the genome. The mutational inactivation of 
two chromosomal genes, a UvrD-like helicase or a serine/threonine kinase, 
during coevolution with the plasmid reduced the expression of the plasmid 
encoded rep system, thus restored the transcriptional profile of the cells. It was 
likely that the rep system was interfering with chromosomal replication, 
triggering the SOS response and stalling cell division (San Millan et al., 2015). A 
recent study examining the amelioration of a costly MDR plasmid, RP4 within 
Pseudomonas sp. H2, also observed that mutations within chromosomal 
helicases compensated for the cost of the plasmid (Loftie-Eaton et al., 2017). 
Interestingly, these mutations also improved the persistence of other broad-
host-range plasmids, suggesting that mutations within helicases that adversely 
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interact with plasmids may be a general mechanism for the adaptation of 
plasmid carriage.  
 
1.5.2.2 Plasmid adaptation 
The burden of plasmid carriage can also be reduced through mutation on the 
plasmid (Porse et al., 2016; Sota et al., 2010). Following 1000 generations of 
coevolution between the broad-host-range IncP-1β plasmid pMS0506 and host 
Shewanella oneidensis, Sota et al. (2010) observed that the plasmid had 
increase stability within both the coevolved and ancestral hosts. Parallel 
mutations within the plasmid replication initiation protein TrfA not only reduced 
the cost of the plasmid within S. oneidensis but also increased its stability within 
other naïve hosts. This provides evidence that unoptimised rep systems of naïve 
plasmids are an important source of the cost of plasmid carriage. However, 
other non-essential elements within plasmids can also contribute to their cost. 
Porse et al (2016) determined that a 25 kb region of large conjugative MDR 
plasmid was the major contributor to the burden it imposed upon its hosts. 
Compensatory evolution through IS26-mediated deletion of the costly region 
allowed stable maintenance of the plasmid.  
 
1.5.2.3 Coadaptation 
Co-adaptation of both the plasmid and hosts can also contribute to improved 
fitness (Dahlberg and Chao, 2003; Loftie-Eaton et al., 2016). Following 
experimental evolution of E. coli and one of two plasmids, R1 and RP4, 
reduction in cost required adaptation of both the plasmid and the host 
chromosome (Dahlberg and Chao, 2003). When the evolved plasmid was 
transferred into the ancestral host, the cost of plasmid carriage was reduced, 
suggestive of plasmid adaptation. Additionally, the ancestral plasmid conferred a 
lower cost in the evolved host, suggestive of host adaptation. A recent study 
determined the genetic basis of coevolution between an IncP-1β MDR plasmid 
and its host, Pseudomonas moraviensis (Loftie-Eaton et al., 2016). Evolution 
under antibiotic selection led to plasmid acquisition of a TA system from a native 
plasmid, this, coupled with host mutations, improved plasmid stability. Here, 
compensatory adaptation was indicative of positive epistasis because the 
plasmid and chromosomal mutations alone only provided a slight increase in 
plasmid persistence, but together they greatly increased persistence. 
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It is clear that compensatory adaption is an important route to ameliorate the 
cost of plasmid acquisition, reducing purifying selection against the plasmid, 
thus stabilising plasmids in bacterial populations. However, key outstanding 
questions remain unanswered; how does the mode of compensatory evolution 
following MDR plasmid acquisition vary with antibiotic treatment? What are the 
dynamics of coevolution between plasmid and host, and how repeatable are 
these coevolutionary dynamics? 
  
 
1.6 RK2 Plasmid as a Model System  
 
The work presented in this thesis experimentally tests the interaction between 
the broad-host-range MDR plasmid RK2, and the model organism E. coli, to 
address when the MDR plasmid is selected for and how it evolves with it’s 
hosts. The RK2 plasmid was isolated from Klebsiella aerogenes following an 
outbreak of carbenicillin resistance in P. aeruginosa in the Burns Unit of the 
Birmingham Accident Hospital in 1969 (Ingram et al., 1973). It became evident 
that the RK2 plasmid was transferred from P. aeruginosa and maintained in K. 
aerogenes, before seeding a second outbreak of resistant P. aeruginosa six 
months later (Ingram et al., 1973). Interest in the RK2 plasmid grew due to its 
extreme broad-host-range and the taxonomic diversity of these host species, 
being able to replicate within almost all gram-negative bacteria (Schmidhauser 
and Helinski, 1985). RK2 is a 60-kb self-transmissible plasmid encoding ARGs 
against ampicillin via a TEM-1 β-lactamase, tetracycline via a tetA/R efflux 
pump, and kanamycin via a phosphotransferase (Figure 1.4) (Pansegrau et al., 
1994). The replication and copy number of RK2 (approximately 5 in E. coli) is 
controlled by one of two initiator proteins, depending on its host (Durland et al., 
1990; Solar et al., 1998), and stability of the plasmid is provided by active 
partitioning and TA systems (Pansegrau et al., 1994). The conjugation 
apparatus is clustered within two modules, tra1 and tra2, encoding the genes 
required for mate pair formation and DNA transfer (Bingle et al., 2003; Zatyka et 
al., 1994). The RK2 plasmid provides an ideal model system to test evolutionary 
questions posed above due to the range of qualitatively different modes of 
resistances it encodes as well as the extensive knowledge of the plasmid’s DNA 
sequence, regulation and control systems. 
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Figure 1.4 The RK2 plasmid, regions colour coded by functional groups. Scale 
in kb. Rep region encodes initiation factors controlling plasmid replication. Tra1 
and Tra2 encode conjugation machinery. The Par region controls active 
partitioning, Kil regions encode genes required for host lethality controlled by the 
Ctl region. There are two MGEs encoded within RK2, insertion sequence IS21 
and transposon Tn1 encoding β-lactamase. An efflux pump that is negative 
regulated in the absence of tetracycline provides tetracycline resistance, 
encoded by tetA and tetR. Kanamycin resistance is provided aphA encoding an 
aminoglycoside 3'-phosphotransferase. Created using the complete nucleotide 
sequence of RK2 produced by Pansegrau et al. (1994). 
 
 
1.7 Chapter Overview 
The thesis focuses on the sociality of resistance and the coevolution of plasmids 
and hosts when under positive selection, specifically: 
 
Chapter 2 – Selective conditions for a multidrug resistance plasmid depend on 
the sociality of antibiotic resistance: 
The sociality of antibiotic resistance encoded upon a MDR plasmid may alter the 
selective conditions required to maintain plasmids. To test this hypothesis I 
compared the concentrations of antibiotic required to select for two qualitatively 
different resistance mechanism encoded on the MDR plasmid RK2. In this 
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chapter I show that the antibiotic concentrations selecting for the RK2 plasmid in 
E. coli depend upon the sociality of the drug resistance: the selection for selfish 
drug resistance (efflux pump) occurred at very low drug concentrations, just 
1.3% of the MIC of the plasmid-free antibiotic-sensitive stain, whereas selection 
for cooperative drug resistance (modifying enzyme) occurred at drug 
concentrations exceeding the MIC of the plasmid-free strain. Combining the two 
antibiotics at concentrations that alone do not select for resistance, selected for 
both resistance mechanisms. These results suggest that selfish resistances will 
be particularly important for the selective maintenance and spread of MDR 
plasmids.  
 
Chapter 3 – Mode of antibiotic action and mechanism of resistance jointly shape 
selection for antibiotic resistance: 
I theoretically investigate the effect of mode of antibiotic action and mechanism 
of resistance upon the selection for resistance. I demonstrate that the accurate 
prediction of the selection for resistance can only be achieved when 
mathematical models include whether antibiotics are bacteriostatic or 
bactericidal, and whether the antibiotic is inactivated by the resistance 
mechanism or not. I further predict that inactivation of bacteriostatic antibiotics 
by resistant bacteria provides greater protection to sensitive bacteria within a 
population than the inactivation of bactericidal antibiotics, leading to weaker 
selection for resistance. The chapter highlights the importance of understanding 
both the sociality of resistance and the antibiotic mode of action when predicting 
the selective conditions of resistance. 
 
Chapter 4 – Adaptive modulation of antibiotic resistance through intragenomic 
coevolution: 
Increasing evidence is pointing to compensatory coevolution between plasmid 
and host playing a key role in stabilising MDR plasmids within bacterial 
populations (Loftie-Eaton et al., 2016; McNally et al., 2016). In this chapter I 
address the outstanding question; how does the mode of compensatory 
adaptation vary with antibiotic treatment? I found that routes to compensatory 
adaptation were different between tetracycline selection and ampicillin-only or 
no antibiotic selection. I discovered that coevolution between the MDR plasmid 
RK2 and E. coli under tetracycline selection followed an unexpected and 
counterintuitive trajectory that was not observed under the other antibiotic 
treatments. Intragenomic coevolution ameliorating the cost of plasmid encoded 
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tetracycline resistance led to co-dependency between the plasmid and host 
chromosome; the resulting co-dependent genome provided high-level, low-cost 
resistance. This work demonstrates how gaining resistance plasmids can be just 
the start of the evolution of antibiotic resistance; gaining a MDR plasmid is a 
dynamic evolutionary process driven by the costs of expressing horizontally 
acquired ARGs. 
 
Chapter 5 – High repeatability of bacteria-plasmid coevolution under antibiotic 
selection: 
I extend the work presented in Chapter 4 to determine the repeatability of 
plasmid-host co-evolutionary dynamics. Through whole genome sequencing of 
clones isolated across the 530 generations of evolution from four independently 
evolving tetracycline populations presented in the previous chapter, I examine 
the temporal order of mutation acquisition. I show that the dynamics of 
coevolution can be strikingly parallel despite clonal interference between 
multiple competing lineages. The order of beneficial mutations was identical 
across all independent replicate populations examined. Evidence points towards 
mutations with the largest phenotypic effect being selected first, with mutation 
that induce smaller phenotypic effect being selected later in time. The study 
provides evidence that reciprocal coevolution between bacteria and plasmids 
can be highly repeatable, with mutations on the chromosome and plasmid 
following a specific path. 
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2. Selective Conditions for a Multidrug Resistance Plasmid 
Depend on the Sociality of Antibiotic Resistance 
 
The following chapter is adapted from the published article: Bottery, M.J., Wood, 
A.J., and Brockhurst, M.A. (2016). Selective conditions for a multidrug 
resistance plasmid depend on the sociality of antibiotic resistance. Antimicrob. 
Agents Chemother. AAC. 60, 2524-2527. M.A.B. and A.J.W. supervised the 
project. M.J.B. performed the experiments and analysed the data. All authors 
contributed towards the design of the study and wrote the manuscript. Data from 
the paper summarized in figures 2.1 and 2.3. Additional data on frequency 
depend selection was acquired after the publication of the paper. 
 
 
2.1 Abstract 
 
Multiple antibiotic resistance genes (ARGs) are frequently clustered on 
conjugative plasmids, which are an important source of clinical resistance. It is 
critical therefore to understand the selective conditions promoting the spread of 
these multidrug resistance (MDR) plasmids. Here, we tested how the antibiotic 
conditions required to select for a multidrug resistant plasmid, RK2, in 
Escherichia coli depended on the mechanism of resistance, specifically whether 
drug resistance was selfish or cooperative. We observed highly contrasting 
selective conditions depending upon the sociality of resistance: a selfish drug 
resistance, efflux of tetracycline, was selected for at ~1% of the minimum 
inhibitory concentration (MIC) of the plasmid-free antibiotic-sensitive strain, 
whereas, a cooperative drug resistance, enzymatic inactivation of ampicillin, 
was only favoured at antibiotic concentrations exceeding the MIC of the 
plasmid-free strain. When used in combination, dual antibiotic selection was 
additive and thus selected for the MDR plasmid at concentrations even lower 
than those observed to be selective under single antibiotic treatments. Finally, 
we show that selection for cooperative resistance, unlike selfish resistance, is 
strongly favored when resistance is rare within a population. These results 
suggest that selfish drug resistances, such as efflux pumps, are likely to play an 
important role in the dynamics of MDR plasmids in the environment where they 
can be selected for by very low, sub-MIC concentrations of antibiotic.    
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2.2 Introduction 
 
Antibiotics are critical to modern medicine, but their widespread use and misuse 
have led to the evolution of strains resistant to most commonly used antibiotics 
(Bush et al., 2011; Laxminarayan et al., 2013). Antibiotic resistance has become 
a major threat to global health, with multidrug-resistant (MDR) bacteria observed 
globally (World Health Organization, 2014). Environmental antibiotic resistance 
genes (ARGs) are a major source of clinical resistance (Berendonk et al., 2015). 
ARGs can be selected for at very low concentrations of antibiotics, far below the 
MIC of sensitive cells (Gullberg et al., 2011, 2014), with antibiotic contamination 
at sub-MICs being proposed as the main driving force behind environmental 
selection for resistance (Andersson and Hughes, 2014; Liu et al., 2011; 
Sandegren, 2014). However, ARGs can encode qualitatively different forms of 
resistance, ranging from selfish to cooperative. Selfish drug resistances confer a 
benefit only to the individual cell harboring them, for example, efflux pumps, 
reduced membrane permeability, and antibiotic target alteration (Blair et al., 
2015). In contrast, cooperative antibiotic resistance benefits both the resistant 
cell and surrounding cells, whether they are resistant or not. For example, 
modifying enzymes, such as β-lactamases, inactivate the antibiotic through 
hydrolysis, decreasing its environmental concentration. Localization of the β-
lactamase enzyme in the periplasmic space may enhance the share of the 
benefit for the resistant cell, but nevertheless, the decrease in the overall 
environmental concentration of antibiotic will benefit both resistant and sensitive 
cells (Vega and Gore, 2014).  
 
We hypothesized that the sociality of drug resistance alters the selective 
conditions for the spread of ARGs (Conlin et al., 2014; Yurtsev et al., 2013). 
Specifically, because the benefits of selfish drug resistance are directed solely 
to the resistant cell, whereas the benefits of cooperative drug resistance are 
shared between resistant and sensitive cells, we predicted that selfish drug 
resistance should be selected at lower relative drug concentrations (i.e., % of 
the sensitive MIC) than those for cooperative resistance. These contrasting 
modes of resistance may also determine whether selection for resistance is 
frequency dependent (Conlin et al., 2014; Dugatkin et al., 2005; Levin et al., 
1988; MacLean and Gudelj, 2006; Ross-Gillespie et al., 2007; Yurtsev et al., 
2016). We would expect that as cooperative resistance provides a public good 
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via the inactivation of the antibiotic, the survival of sensitive cells would 
depended upon the frequency of cooperators within a population. In contrast, 
selfish drug resistances do not alter the survival of sensitive cells and therefore 
selection for a selfish resistance would not be frequency dependent.  
 
Multiple ARGs are frequently clustered together onto conjugative plasmids, 
including combinations of selfish and cooperative drug resistances (Carattoli, 
2013). How combinatorial antibiotic usage selects for MDR plasmids is not clear, 
especially for combinations of antibiotics requiring qualitatively different modes 
of drug resistance, such as selfish or cooperative drug resistance. Here, we 
tested how the sociality of drug resistance and single versus combined antibiotic 
treatment altered the selective conditions for the MDR plasmid RK2 (Pansegrau 
et al., 1994) in Escherichia coli MG1655. RK2 carries genes encoding both 
cooperative ampicillin resistance, mediated by a β-lactamase, and selfish 
tetracycline resistance, mediated by an efflux pump. We report that the selfish 
drug resistance is selected for at far lower relative antibiotic concentrations than 
those for cooperative drug resistance and that combined antibiotic selection is 
additive, showing no interaction. Furthermore, we show that the selection for 
cooperative breakdown of ampicillin is strongly frequency dependent, whereas 
the selfish efflux of tetracycline is not. Therefore the selection for the 
cooperative RK2 plasmid can be manipulated, ranging from highly cooperative 
under ampicillin conditions, though non-cooperative in the absence of ampicillin, 
to selfish in the presence of tetracycline.  
 
 
2.3 Materials and methods 
 
2.3.1 Strains, culture conditions 
Two isogenic E. coli MG1655 strains chromosomally labelled with GFP or 
mCherry were used for direct competition. These strains are labelled at the 
neutral insertion site attB lambda through λ red homologous recombination. 
Both strains were provided by the Van Der Woude lab (University of York). The 
RK2 multidrug resistance plasmid was introduced to the marker strains through 
conjugation from E. coli MV10(RK2) provided by the Thomas lab (University of 
Birmingham). Transconjugants were selected on nutrient broth agar plates 
supplemented with tetracycline 10 µg ml-1. As there was no antibiotic resistance 
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selectable marker on the chromosome of the fluorescently labelled cells, 
transconjugants were distinguished through detection of fluorescent markers 
using Zeis Stereo Lumar v12 microscope. Presence of the RK2 plasmid was 
confirmed by PCR using RK2 specific primers amplifying the plasmids origin of 
replication, oriV (Fw: cccatcatgaccttgccaag Rv: gtaacagatgagggcaagcg). All 
cultures were conducted in Oxoid® Nutrient Broth (NB) at 37°C, shaken at 180 
rpm, 5 ml in 50 ml microcosms unless otherwise stated.  
 
2.3.2 MIC measurements 
To measure minimal inhibitory concentrations (MIC), six replicate cultures of 
plasmid free E. coli MG1655 and six replicate cultures of E. coli MG1655(RK2) 
were grown overnight until stationary phase in 5 ml NB, the saturated cultures 
were then sub-cultured 50 µl into 5 ml fresh NB and grown to an OD600 of 0.5. 
These were then diluted into 96-well plates containing gradients of ampicillin 
(ranging from 0 µg ml-1 to 4096 µg ml-1) or tetracycline (ranging from 0 µg ml-1 to 
256 µg ml-1) antibiotics in nutrient broth, to an initial density of 5×105 CFU ml-1. 
100 µl cultures were grown for 24 hours 37°C shaken at 600 rpm, 3 mm orbital 
radius. OD600 was measured after 24 hours. The MIC was defined as the lowest 
concentration that inhibited all bacterial growth. These conditions informed the 
antibiotic conditions used to in competitive fitness assays. 
 
2.3.3 Growth curves 
Growth curves of E. coli MG1655 with and without RK2 plasmid were conducted 
in monoculture. Three independent replicate microcosms were inoculated with 
individual colonies of MG1655 with and without the RK2 plasmid and grown to 
saturation over night. These were sub-cultured 50 µl into 5 ml NB and grown for 
2 hours until OD600 of 0.5. The sub-cultures were used to inoculate 100 µl NB in 
96-well plates to a final dilution of 1:400. The plates were incubated at 37°C with 
shaking at 300 rpm, 3 mm orbital radius for 24 hours, with OD600 measured 
every 30 minutes using a Tecan infinite M200 Pro plate reader. 
 
Growth curves of plasmid free E. coli MG1655 were conducted to determine the 
sub-MIC growth response to ampicillin and tetracycline. Three independent 
replicate saturated overnight cultures were sub-cultured to an OD600 of 0.5, and 
used to inoculated 100 µl NB supplemented with either 0, 2, 4, 6, 8, or  
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10 µg ml-1 ampicillin or 0, 0.3, 0.6, 0.9, 1.2, 1.5, 1.8, 2.1 2.4, or 2.7 µg ml-1 
tetracycline in 96-well plates at a final dilution of 1:400. Plates were grown at 
37°C with shaking at 300 rpm, 3 mm orbital radius for 48 hours, OD600 was 
measured every 30 minutes by Tecan infinite M200 Pro plate reader.  
 
2.3.4 Relative fitness 
The relative fitness of plasmid bearing versus plasmid free cells was estimated 
by direct competition experiments. To control for fitness effects of the 
fluorescent markers, competitions were performed with the plasmid carried in 
the MG1655-gfp background against plasmid-free MG1655-mcherry for half of 
the replicates, and vice versa for the other half of the replicates. Competitions 
were conducted across antibiotic concentration gradients, ranging from no 
antibiotic to 12 µg ml-1 ampicillin or 250 ng ml-1 tetracycline. Six replicates of 
each antibiotic concentration were conducted. The competitions were initiated 
with 1:1 mixtures of plasmid-bearing against plasmid-free strains from overnight 
cultures at an initial density of approximately 5×105 CFU ml-1. To gain exact 
viable cell counts, dilutions of culture were spread on to nutrient agar plates. 
Competition cultures were grown for 24 hours in 100 µl NB within 96 well plates 
at 37°C, 600 rpm. Final densities calculated via plate counts, strains were 
distinguished through detection of fluorescent markers using Zeis Stereo Lumar 
v12 microscope. The relative fitness of plasmid-bearing bacteria was calculated 
as a ratio of Malthusian parameters (Lenski et al., 1991): 
 
𝑊!"#$%&' = ln 𝑁!"#$%,!"#$%&'𝑁!"!#!$%,!"#$%&'
ln
𝑁!"#$%,!"##𝑁!"!#!$%,!"##  
 
No significant difference between growth dynamics of marker strains was 
observed (Figure S2.1), along with no significant difference in relative fitness 
when plasmid free MG1655-gfp and -mcherry strains were directly competed 
(Figure S2.2, t-test difference from 1 t11 = 0.6001, p = 0.5606).  
 
2.3.5 Frequency dependent selection 
Frequency dependent selection was measured through direct competition 
between E. coli MG1655 and E. coli MG1655(RK2) at different starting 
frequencies. As with the relative fitness calculations, to control for fitness effects 
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of the differentially fluorescently marked strains, 3 replicate competitions per 
treatment were conducted with the RK2 plasmid in the MG1655-gfp background 
and 3 replicate competitions were conducted with the RK2 plasmid in the 
MG1655-mcherry background. Competitions were initiated with either 1:99, 1:9, 
1:1, 9:1 or 99:1 mixtures of plasmid-bearing strains and with plasmid-free strains 
from overnight monocultures grown in 5 ml non-selective NB media. These 
mixtures were used to inoculate 100 µl NB containing either 0, 4, 8, or 12 µg ml-1 
of ampicillin or 0, 13, 26 or 39 ng ml-1 of tetracycline at a final dilution of 1:400. 
The strains were competed for 24 hours at 37°C, 600 rpm in 96 well plates. To 
detect very low proportions of each competing strain, cell densities at the start 
and end of the competition were determined through flow cytometry. Saturated 
populations were diluted to 1:1000 in sterile 22 µm filtered PBS, and stained 
with 1 µg ml-1 DAPI to distinguish between cells and background noise. Cells 
were first gated from the background electrical noise using FSC and SSC, and 
then gated on a positive DAPI signal using 450/45 channel on a 405 nm laser. 
Sub-populations of plasmid containing and plasmid free cells were gated on 
GFP signal using 525/40 channel on a 488 nm laser (Figure S2.3). All gating 
was conducted using R3.3.3 {flowCore}. Selection rate (r) was calculated as the 
difference between the plasmid bears and plasmid free Malthusian growth 
parameters: 
 𝑟!"#$%&' = ln 𝑁!"#$%,!"#!"#$𝑁!"!#!$%,!"#$%&' − ln 𝑁!"#$%,!"##𝑁!"!#!$%,!"##  
 
Which gives the absolute difference in density over 24 hours between the two 
strains. This measure of fitness is preferable when comparing strains were one 
competitor is much less fit than the other (Travisano and Lenski, 1996). 
 
2.3.6 Statistics 
Significant difference between two related samples was calculated using two 
sided, two-sample t-test. Shapiro-Wilk test was conducted to check for 
normality. Interacting effects of co-treatment with ampicillin and tetracycline 
were calculated using multiple linear regression with antibiotics are interacting 
terms. The effects of frequency of resistances and concentration of antibiotic 
upon fitness were calculated using multiple linear regression with frequency and 
concentration as interacting terms. All statistical analysis was conducted in R 
(version 3.2.3). 
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2.4 Results 
 
2.4.1 Sub-MIC effect of antibiotics on growth 
Conventionally, ARGs are thought to be positively selected for at antibiotic 
concentrations exceeding the MIC of sensitive cells in monoculture (Hughes and 
Andersson, 2012). This is referred to as the conventional selective window 
(Figure 2.1), and is the concentration required to reduce to reduce the growth of 
a bacterial population to undetectable levels. This is the basis of calculating the 
dosage of antibiotics within clinical settings, with the aim to clear an infection 
through maintaining antibiotics concentrations above a bacteria’s MIC. Due to a 
focus on resistance phonotypes with high levels of resistance, how antibiotic 
concentrations below the MIC of sensitive cells selects for resistance is often 
overlooked. Importantly, growth of sensitive strains is reduced when exposed to 
concentrations of antibiotic insufficient to kill them, which may lead to the 
selection for resistance (Figure 2.1). 
 
 
 
Figure 2.1 | Cell density (optical density at 600 nm [OD600]) of sensitive plasmid-
free bacteria (green line) and resistant plasmid containing bacteria (blue line) as 
a function of ampicillin concentration (A) and tetracycline concentration (B) after 
24 h of growth in monoculture. The error bars show standard error of the mean 
(SEM) values (n = 6). The area shaded in green shows the sub-MIC selective 
window, and the area shaded in blue shows the selective window conventionally 
thought to select for resistance. 
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To determine the impact of sub-MIC concentrations of tetracycline and ampicillin 
we measured the growth of plasmid free MG1655 across a gradient of sub-
inhibitory concentrations of antibiotic. Sub-MIC concentrations of both ampicillin 
and tetracycline increase the length of the lag phase and decrease the growth 
rate and carrying capacity of the sensitive bacterial populations (Figure 2.2). 
Ampicillin acts as bactericidal at concentrations exceeding the MIC, inhibiting 
cell wall synthesis and causing cell lysis (Waxman and Strominger, 1983), 
however, below the MIC ampicillin can produce bacteriostatic effects, reducing 
and inhibiting bacterial growth (Thonus et al., 1982). A transition between 
bactericidal and bacteriostatic mode of action may be evident in the sharp 
decrease in growth after 6 µg/ml (Figure 2.2A). This transition in mode of action 
may be the cause of the hill type shape of the MIC curve, whereby there is a 
slow reduction in growth at low concentrations of antibiotic which increases at 
higher concentrations (Figure 2.1A). In contrast, tetracycline is through to act 
predominately as a bacteriostatic (Chopra and Roberts, 2001), as a result 
increased concentrations of tetracycline linearly decrease growth of sensitive 
bacteria (Figure 2.2B). 
 
 
 
 
Figure 2.2 | Sub-MIC sensitivity of plasmid free E. coli MG1655 to ampicillin 
(bactericidal) and tetracycline (bacteriostatic). Growth curves (OD600) of plasmid 
free E. coli MG1655 in increasing concentrations of (A) ampicillin and (B) 
tetracycline. Dotted vertical line represents the 24-hour mark at which 
competition and MIC cultures are measured for relative fitness and growth 
respectively. Lines show mean of three biological replicates per treatment with 
error bars representing SEM.  
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2.4.2 Selective conditions of Multi-drug resistance 
To determine whether the sociality of resistance affected the selection window 
for the RK2 MDR plasmid, we estimated the relative fitness of plasmid-bearing 
versus isogenic plasmid-free cells by direct competition, according to standard 
methodology. In the absence of antibiotics, the plasmid imposed a significant 
cost of carriage, decreasing the fitness of E. coli by 19% (Figure 2.3A and B, t 
test, P = 0.001, t = 9.8674, df = 23). An intrinsic cost is often associated with 
plasmid carriage when accessory traits are not under positive selection due to 
cellular disruption and increased translational load (Baltrus, 2013). Cooperative 
ampicillin resistance was positively selected at ampicillin concentrations 
exceeding the MIC of plasmid-free sensitive E. coli strains (Figure 2.3A). 
Importantly, sensitive cells were able to maintain positive growth in mixed 
cultures at ampicillin concentrations that completely inhibited their growth in 
monoculture (>8 µg/ml; Figure 2.1A; see also Figure S2.4 in the supplemental 
material), justifying the assignment of ampicillin resistance as cooperative. Thus, 
cooperative resistance permits the persistence of a sensitive subpopulation 
beyond the sensitive MIC due to the inactivation of the antibiotic, potentially 
allowing reinvasion by sensitive cells once the antibiotic concentration is 
sufficiently reduced by the action of resistant cells. 
 
In contrast, selfish tetracycline resistance was positively selected at tetracycline 
concentrations of just 1.3% of the MIC of sensitive E. coli (Figure 2B). Indeed, at 
concentrations of tetracycline that were >10% of the MIC of sensitive E. coli, the 
resistant plasmid bearers competitively excluded the plasmid-free bacteria, with 
no plasmid-free cells observable (see Figure S2.5). This is despite the fact that 
plasmid-free E. coli survived at these tetracycline concentrations when grown 
alone (Figure 2.1B). Our data suggest that selfish tetracycline resistance is 
positively selected in the sub-MIC selective window at very low tetracycline 
concentrations, similar to those observed in the natural environment (Zhang and 
Li, 2011). 
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Figure 2.3 | Fitness reaction norms as a function of antibiotic concentration 
during competition experiments between E. coli harboring the RK2 plasmid and 
isogenic plasmid-free sensitive strains. Competition in the presence of ampicillin 
(A) and tetracycline (B) is shown, and the red lines show a fitted regression. 
Dashed lines represent antibiotic concentrations predicted to select for RK2 
plasmid. (C and D) Fitness reaction norms of combination treatments with both 
ampicillin and tetracycline during competition experiments between E. coli 
harboring the RK2 plasmid and plasmid-free strains; these are alternative 
visualizations of the same experimental data. There is no significant interaction 
of antibiotic treatments upon the relative fitness (F1,68 = 0.2395, P = 0.6261), 
indicating that treatments were non-interacting and additive. The error bars in 
panels A, C, and D show the SEM values (n = 6). Antibiotic concentrations are 
shown as percentages of the MIC for sensitivity. 
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antibiotics were used in combination, their selective effects were independent 
and additive (Figure 2.3C). This means that very low concentrations of 
tetracycline were sufficient to completely mask the population-level effects of 
cooperative ampicillin resistance. With increasing tetracycline concentrations, 
the ampicillin concentration positively selecting for the MDR plasmid shifted to 
lower and lower sub-MIC levels, reducing the window of selective conditions 
under which sensitive cells could persist (Figure 2.3D). 
 
Residues of multiple antibiotics are commonly found to contaminate the same 
environments at low concentrations (Batt et al., 2006; Zhang and Li, 2011). 
These combinations, and particularly the presence in the environment of 
antibiotics, like tetracycline, targeted by selfish efflux mediated resistance will 
select for the spread of MDR plasmids and competitive exclusion of sensitive 
cells. This is despite being present at concentrations far below the level required 
to positively select resistance individually. This adds further evidence that 
ARGs, whether chromosomal or carried by plasmids, can be positively selected 
at antibiotic concentrations far below the MIC of sensitive strains (Gullberg et al., 
2011, 2014; Liu et al., 2011). 
 
2.4.3 Social resistance and frequency dependence 
Next we determined whether the starting frequency of resistance within a 
population altered at what concentration resistance was selected for, i.e. 
whether selection for the resistances were frequency dependent. Relative 
fitness of plasmid bearing versus plasmid free cells was estimated across a 
range of initial plasmid frequencies and antibiotic concentrations (Figure 2.4B, 
2.4D). Both tetracycline concentration (F1,116 = 119.28, p < 0.01) and frequency 
of resistance (F1,116= 33.49, p < 0.01) have significant effects on the selection 
rates of the RK2 plasmid. However, both predictors did not show a significant 
interaction (F1,116 = 1.186, p = 0.2784), indicating that the concentration of 
tetracycline and frequency of resistance in a population are independent. 
Therefore selection for the efflux of tetracycline is not altered by the frequency of 
resistance within the population, and only very low concentration of tetracycline 
are required to select for the selfish resistance independent of the fraction of 
resistance in the population.  
 
In contrast, the starting frequency of plasmid-bearing antibiotic-resistant bacteria 
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within a population greatly affects the concentration of antibiotic required to 
select for cooperative ampicillin resistance (Figure 2.4A, 2.4C). At low starting 
frequencies of plasmid-bearing cells (one tenth of the total population), the 
concentration of ampicillin required to select for resistance is reduced to below 
44% of the sensitive MIC. Where as, when the starting frequency of plasmid-
bearing cells is high within a population (nine tenths of the total population), the 
concentration of ampicillin required to select for resistance increased to above 
133% of the sensitive MIC.  Both the concentration of ampicillin (F1,116 = 103.69, 
p < 0.01) and the frequency of plasmid within the population (F1,116 = 350.925, p 
< 0.01) are significant predictors of the selection rate of the resistant cells. But 
unlike the selfish tetracycline resistance, ampicillin concentration and frequency 
of plasmid have a significant interaction (F1,116 = 44.914, p < 0.01). The 
interaction of selective environment and frequency of resistance results in  
negative frequency dependent selection for cooperative resistance, whereby 
selection for resistance is stronger when resistance is rare. A lower frequency of 
plasmid containing bacteria within a population may result in a lower average 
inactivation rate of antibiotic, providing little or no protection to plasmid sensitive 
cells within the environment. The reduced protection provided by the resistant 
cells results in positive selection for resistance at lower relative concentrations 
of antibiotic. Taken together these finding suggest that selfish resistances are 
important for maintaining multi-drug resistance plasmids independent of 
frequency within a population, but cooperative resistances are equally as 
important for the selective maintenance when the plasmid is rare in a 
population.   
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Figure 2.4 | Log10 selection rates (r) of plasmid bearing E. coli vs plasmid free 
E. coli as a function initial plasmid frequency under (A,C) ampicillin selection 
and (B,D) tetracycline selection. Points show means of six independent 
replicates; with error bars showing SEM. C and D show the same data plotted 
as heat maps. Selection rates were measured at frequencies of 0.01 and 0.99, 
these measurements have been omitted from the plot for clarity, however, the 
stats presented in the text include these measurements. Plots containing this 
additional data can be found in the supplementary information, Figure S2.6. 
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2.5 Discussion 
 
Here, we show that the extent to which an ARG is positively selected at sub-
MICs depends upon the sociality of the mechanism of drug resistance. 
Cooperative ampicillin resistance is positively selected at ampicillin 
concentrations exceeding the MIC, whereas selfish tetracycline resistance is 
positively selected at 100-fold-lower relative drug concentrations. This striking 
difference in the selective window for ARGs located on the same MDR plasmid 
probably arises because of the population-level effects of the ARGs: cooperative 
ampicillin resistance allowed sensitive bacteria to survive at concentrations 
above their MIC by reducing the ampicillin concentration and sharing the 
benefits of resistance, whereas selfish tetracycline resistance drove the 
complete competitive exclusion of sensitive cells at >10% of the MIC due to the 
exclusively individual benefits of efflux-mediated resistance. These contrasting 
mechanisms of resistance also lead to frequency dependent selection of 
cooperative ampicillin resistance but not selfish tetracycline resistance. 
Combining the two antibiotics at concentrations that would not normally select 
for resistance individually selects for both resistances and the spread of the 
MDR plasmid.  
 
Our study has a number of possible limitations: First, it is possible that other 
factors in addition to sociality may have contributed to differences in the fitness 
reaction norms of the antibiotics, including the contrasting effects of sub-MICs 
on monoculture densities, and the fact that ampicillin is bactericidal while 
tetracycline is bacteriostatic. Second, we use exemplars of cooperative and 
selfish resistance, but more research will be required to test the importance of 
sociality on the selective conditions for other resistance mechanisms. 
 
Understanding when antibiotic resistance is selected for within bacterial 
population is a central goal in studying the spread of resistance. Our findings 
suggest that selfish efflux-mediated drug resistances are likely to be especially 
important for the selective maintenance and spread of MDR plasmids 
independent of the frequency of resistance in the populations. However, 
cooperative resistances are likely to be equally as important for the selective 
maintenance when the plasmid is rare in a population. 
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3. Mode of Antibiotic Action and Mechanism of Resistance 
Jointly Shape Selection for Antibiotic Resistance 
 
 
3.1 Abstract 
 
The acquisition and spread of bacterial resistance to antibiotics threatens global 
public health. Mathematical models have proved to be a key tool in aiding our 
understanding of antibiotic resistance. Pharmacokinetic and pharmacodynamics 
(PK-PD) models are used to predict optimal dosage and antibiotic regimens 
targeted at specific pathogens. However, PK-PD models often omit important 
biological details that affect selection for resistant genotypes, limiting their 
usefulness for predicting resistance evolution. Here, we develop simple models 
parameterised with experimental data for two antibiotics, tetracycline and 
ampicillin, that differ in their modes of action and mechanisms of resistance. We 
show that selection for resistance can only be accurately predicted when models 
include whether antibiotics are bactericidal or bacteriostatic, and whether 
resistance involves inactivation of the antibiotic or not. We further demonstrate 
that inactivation of bacteriostatic antibiotics provided more protection to sensitive 
cells within a population than inactivation of bactericidal antibiotics, leading to 
weaker selection for resistance. 
 
 
3.2 Introduction 
 
The global spread of antimicrobial resistance (AMR) within bacteria is a major 
threat to both routine and critical care, as the drugs we rely on to cure infections 
diminish in effectiveness (Laxminarayan et al., 2013). Mathematical models 
have proven to be a valuable tool in understanding the population dynamics of 
bacteria under antibiotic treatment (Czock and Keller, 2007; Jacobs et al., 
2016). Techniques such as pharmacokinetic-pharmacodynamic modelling (PK-
PD) are used to predict optimal dosage and antibiotic regimens targeted at 
specific pathogens (Chung et al., 2006; Mouton et al., 1997), but can also be 
applied to predict the emergence and subsequent selection of resistance 
(Lipsitch and Levin, 1997). The minimum inhibitory concentration (MIC) of 
sensitive cells is commonly used in combination with these models to predict the 
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concentration of antibiotic required to clear infection and the probability for 
resistance to arise (Drlica, 2003). 	
Within host PK-PD models commonly assume an antibiotic effect to be 
bactericidal (Jacobs et al., 2016), however the mode of action of antibiotics 
ranges from bacteriostatic – reducing the growth rate of a cell – to bactericidal – 
directly killing the cells. This fundamental difference in the mode of action of 
antibiotics is likely to alter selection for resistance in bacterial populations simply 
because sensitive cells are merely outgrown rather than killed under treatment 
by bacteriostatic antibiotics (Pankey and Sabath, 2004). Similarly, PK-PD 
models often have simple approximations of resistance whereby all the benefit 
of resistance is directed to the resistant sub-population. While this is likely to be 
the case for certain mechanisms of resistance, it is not appropriate for 
mechanisms of resistance that inactivate the antibiotic itself. When resistance is 
mediated by a mechanism that does not change the environmental 
concentration of antibiotic – such as efflux pumps, alteration of target site or 
target site protection via antibiotic release (Dönhöfer et al., 2012; Rahman et al., 
2017) – the benefit of resistance is purely directed towards the resistant cell. In 
contrast, enzymatic inactivation of an antibiotic, such as by β-lactamases or 
acetyltransferases, decrease the local concentration of antibiotic. This provides 
high levels of resistance to the producers but also lowers the environmental 
concentration of antibiotic and thereby allows some sensitive cells to persist in 
the population, providing collective resistance (Dugatkin et al., 2005; Sorg et al., 
2016; Yurtsev et al., 2013). Recent experimental studies suggest that this 
difference in the mechanism of antibiotic resistance alters the concentration of 
antibiotic required to select for resistance in mixed populations containing 
resistant and sensitive genotypes (Bottery et al., 2016). 
 
We develop a simple mathematical model that incorporates both bacteriostatic 
and bactericidal terms, as well as modes of resistance that do or do not 
inactivate the antibiotic. The model is parameterised against published data for 
sensitive and resistant strains of Escherichia coli where resistance is provided 
by the plasmid RK2 (Bottery et al., 2016). RK2 encodes resistance genes 
against ampicillin, a bactericidal antibiotic for which resistance inactivates the 
drug, and tetracycline, a bacteriostatic antibiotic for which resistance does not 
inactivate the drug. We report that including the mode of antibiotic action and 
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mechanism of resistance in the model greatly improved its power to predict 
selection for resistance, including whether or not selection for resistance is 
frequency dependent. We extended the model to allow all combinations of mode 
of antibiotic action and mechanism of resistance and find that these properties 
interact: inactivation of bacteriostatic antibiotics was predicted to provide more 
protection to sensitive cells within a population than inactivation of bactericidal 
antibiotics.  
 
 
3.3 Methods 
 
3.3.1 Theory 
The model presented here builds upon a within-host PK-PD framework, to 
explore the population dynamics of a mixed population containing both antibiotic 
sensitive and resistant bacteria (Jacobs et al., 2016). The model incorporates 
two different modes of antibiotic action, bacteriostatic which reduces the growth 
rate of cells, and bactericidal, killing cells within the model.  The model also 
includes terms describing two different mechanisms of antibiotic resistance, 
active enzymatic inactivation of the antibiotic, reducing the environmental 
concentration of the antibiotic, and resistance whereby the concentration of 
antibiotic in the environment remains unchanged. The interactions between the 
different components of the model are summarised in Figure 3.1. 
 
The model system tracks two sub-populations of bacteria: antibiotic sensitive 
plasmid free bacteria (𝑆) and antibiotic resistant plasmid containing bacteria (𝑅). Both stains are inhibited to a greater or lesser degree by the concentration 
of antibiotic within the system (𝐴). The bacterial population dynamics when 
under antibiotic treatment, are described by the following set of differential 
equations: 
 d𝑆d𝑡 = 𝛼 − 𝐾𝑚𝑎𝑥!" ∙ 𝐴!(𝐾𝐴!"!")! + 𝐴! 𝑆 1 − 𝑆 + 𝑅𝐾 − 𝐾𝑚𝑎𝑥!" ∙ 𝐴!(𝐾𝐴!"!")! + 𝐴! 𝑆  (1) d𝑅d𝑡 = 𝛽 − 𝐾𝑚𝑎𝑥!" ∙ 𝐴!(𝐾𝐴!"!")! + 𝐴! 𝑅 1 − 𝑆 + 𝑅𝐾 − 𝐾𝑚𝑎𝑥!" ∙ 𝐴!(𝐾𝐴!"!")! + 𝐴! 𝑅  (2) 
 
 
	 50 
And the change in concentration of antibiotic within the system is given by the 
following: d𝐴d𝑡 = −𝑅 𝑉!"# ∙ 𝐴𝑘! + 𝐴  (3) 
 
 
Equations (1-3) aim to understand the population dynamics within a microcosm, 
where nutrient availability is limited, resulting in the bacterial population reaching 
stationary phase within 24 hours. We therefore implemented growth of the two 
sub-populations as logistic terms with a combined carrying capacity K, with 
growth rates for S and R as α and β respectively. As carriage of resistance 
plasmid is often costly (Andersson and Levin, 1999; Baltrus, 2013; Bergstrom et 
al., 2000) we imposed a cost c to the growth rate of resistance cells so that 𝛽 = 1 − 𝑐 𝛼. 
 
 
 
Figure 3.1 | Summary of interactions within the mass action model. Sub-
populations of antibiotic-sensitive plasmid-free 𝑆 and antibiotic-resistant 
plasmid-containing 𝑅 compete, with growth limited by the combined carrying 
capacity 𝐾 of the system. Both 𝑆 and 𝑅 are inhibited by the concentration of 
antibiotic 𝐴 within the system but sensitive cells are affected to a greater extent. 
The antibiotic can either reduce the growth rates 𝛼 and 𝛽, simulating a 
bacteriostatic, or directly remove cells from the model, simulating a bactericidal 
antibiotic. Resistance to the antibiotic is implemented through a higher 𝐾𝐴!" 
than the sensitive population, with cooperative resistance also degrading the 
antibiotic within the system through a Michaelis-Menten kinetic term. 
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The affect of antibiotic upon bacterial growth depends upon the type of antibiotic 
administered. We implemented a bacteriostatic term in equations (1) and (2) as 
a Hill function reducing the growth rate of each bacteria type, (𝐾𝑚𝑎𝑥!" ∙𝐴!)/((𝐾𝐴!"!")! + 𝐴!), dependent on 𝐾𝑚𝑎𝑥!" the maximum reduction in growth 
rate and 𝐾𝐴!"!" the concentration of antibiotic required to achieve 50% of 𝐾𝑚𝑎𝑥!" and the Hill coefficient 𝑚, for 𝑖 = 𝑆,𝑅. The distinguishing factor between 
resistance and sensitivity to the bacteriostatic antibiotic was 𝐾𝐴!"!", we assume 𝐾𝐴!"!" > 𝐾𝐴!"!" representing a lower probability of the antibiotic reaching its 
target in resistance cells. A bactericidal term was implemented as a killing rate, 
removing each bacteria type from the system according to the function (𝐾𝑚𝑎𝑥!" ∙ 𝐴!)/((𝐾𝐴!"!")! + 𝐴!)𝑖, subject to a maximum kill rate 𝐾𝑚𝑎𝑥!", the 
concentration of antibiotic at which 50% of the maximum effect, 𝐾𝐴!"!", and the 
Hill coefficient, 𝑛, for 𝑖 = 𝑆,𝑅. The killing rate was assumed to be equal between 
the sensitive and resistant populations, however the concentration of antibiotic 
which yielded 50% of 𝐾𝑚𝑎𝑥!" differed between the two strains, with 𝐾𝐴!"!" >𝐾𝐴!"!" (Jacobs et al., 2016).  
 
Differentiating resistant and sensitive sub-populations purely through the 
parameters of the antibiotic terms as described above results in resistance that 
is completely privatised, i.e. the benefit of resistance is purely directed towards 
the resistant cells within the population. However, resistance mechanisms that 
inactivate the antibiotic change the local concentration of antibiotic, and 
therefore may alter the selection pressure upon resistant cells within a mixed 
population (Bottery et al., 2016; Livermore, 1997; Nikaido and Normark, 1987; 
Yurtsev et al., 2013). To model the inactivation antibiotic we implemented a 
Michaelis-Menten kinetic term with a per cell maximum achievable antibiotic 
degradation rate (𝑉!"#) and a Michaelis constant (𝑘!) describing the antibiotic 
concentration at which half of 𝑉!"# is achieved.  
 
The equations were solved numerically in R(3.3.3) using the LSODA method 
within the {deSolve} package (Soetaert et al., 2010). Relative fitness (𝑊!) of 
resistant population was calculated by direct comparison of the Malthusian 
growth parameters using the following equation (Lenski et al., 1991): 
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𝑊! = ln 𝑁!"𝑁!!
ln 𝑁!"𝑁!!  
(4) 
 
 
Where 𝑁!" and 𝑁!! are the population densities of resistance cells at time t and 
0 respectively and, 𝑁!" and 𝑁!! are the sensitive population densities at time 
point t and 0 respectively. 
 
3.3.2 Estimation of Model Parameters 
Each function within the model was parameterised independently using either in 
vitro observations, model fitting to previously acquired experimental data, or 
literature values. The logistic growth terms for sensitive bacteria were derived 
from growth experiments of E. coli in the absence of antibiotic, with the cost of 
harbouring the plasmid estimated through direct competition. The effect of each 
antibiotic upon the bacteria was parameterised through fitting to MIC curves. 
The inactivation rates of ampicillin by the RK2 plasmid encoded TEM-1 β-
lactamase were predicted from literature values. Table 3.1 summarises the 
parameters used in the model. 
 
The sensitive bacterial growth rate, 𝛼, was estimated from bacterial growth 
curves conducted in 96 well plates, 100ul cultures in Oxoid Nutrient Broth. The 
doubling time was estimated during logistic growth between 𝑇! = 120 minutes 
and 𝑇! = 240 minutes post inoculation using the following formula: 𝑔 = 1/[(log 𝑁! − log(𝑁!))/(log 2 ∙ (𝑇! − 𝑇!))] where 𝑁! is the optical density at 𝑇!, 𝑁! is 
the optical density at 𝑇!. The fitness cost (𝑐) of plasmid carriage is ~20% as 
measure through direct competition between isogenic plasmid free and plasmid 
containing bacteria in the absence of antibiotics, the growth rate 𝛽 of resistant 
cells estimated as 1 − 𝑐 𝛼. The carrying capacity after 24 hours growth in 5ml 
nutrient broth is approximately 109 cells ml-1 when sensitive and resistant cells 
are grown in co-culture.  
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Table 3.1 | Parameter notation and estimated values used in mass action 
model. References: 1. Bottery et al. (2016), 2. Nikaido and Normark (1987), 3. 
Livermore (1997), 4. Suvorov et al. (2007). 
Parameter Description Units Value Source 𝛼 Growth rate of sensitive plasmid 
free bacteria 
h-1  1.25 This study 
𝑐 Fitness cost of resistance -  0.2 1 𝛽 Growth rate of resistant plasmid 
carrying bacteria, 1 − 𝑐 𝛼 h-1  1.0  𝐾 Carrying capacity  cells ml-1  109 This study 𝐾𝑚𝑎𝑥!"  Maximum growth reduction of 
sensitive bacteria, bacteriostatic 
h-1 Tet 1.25 This study 
𝐾𝑚𝑎𝑥!"  Maximum growth reduction of 
resistant bacteria, bacteriostatic 
h-1 Tet 1.0 This study 
𝐾𝐴!"!"  Antibiotic concentration required 
for half reduction in growth rate 
of sensitive bacteria 
µg ml-1 Tet 0.08 Fitted 
𝐾𝐴!"!" Antibiotic concentration required 
for half reduction in growth rate 
of resistant bacteria 
µg ml-1 Tet 10.6 Fitted 
𝑚 Hill coefficient of antibiotic 
growth reduction term 
- Tet 1.0 Fitted 
𝐾𝑚𝑎𝑥!" Maximum killing rate of sensitive 
bacteria, bactericidal 
h-1 Amp 1.5 Fitted 
𝐾𝑚𝑎𝑥!"  Maximum killing rate of resistant 
bacteria, bactericidal 
h-1 Amp 1.5 This study 
𝐾𝐴!"!" Antibiotic concentration require 
for half maximum death rate of 
sensitive bacteria 
µg ml-1 Amp 4.5 This study 
𝐾𝐴!"!" Antibiotic concentration require 
for half maximum death rate of 
resistant bacteria 
µg ml-1 Amp 3200 Fitted 
𝑛 Hill coefficient of antibiotic death 
term 
- Amp 1.6 Fitted 
𝑉!"#  Maximum antibiotic inactivation 
rate 
µg h-1 cell-1 Amp 9.2×10-6 2  
Tet 0  𝑘!  Antibiotic concentration for half 
maximum inactivation rate 
µg ml-1 Amp 12.9 2, 3, 4 
Tet 0  
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The antibiotic effect terms were parameterised against the MIC curves from 
Bottery et al. (2016). As ampicillin causes the lysis of cells, we assumed 
ampicillin to have a purely bactericidal effect in the model. Half the concentration 
of ampicillin required to reduce growth by half (𝐾𝐴!"!") was estimated from the 
sensitive plasmid free MIC curve as 4.5 µg ml-1. The maximum achievable death 
rate (𝐾𝑚𝑎𝑥!") and Hill coefficient (𝑛) for sensitive cells exposed to ampicillin 
were estimated by fitting simulated death curves of sensitive cells grown in 
monoculture to the MIC data, while keeping the growth rate and carrying 
capacity fixed, along with inactivation rates at zero. As the ampicillin MIC of 
plasmid containing resistant cells is greater than 4 mg ml-1, 𝐾𝐴!"!" was 
parameterised as the minimum value required to achieve growth to within 10% 
of 𝐾 at 4 mg ml-1 ampicillin. Tetracycline binds to the 50S ribosomal subunit 
lowing the growth rate of bacteria; therefore we assumed tetracycline to have a 
purely bacteriostatic effect within the model. Unlike the bactericidal term, the 𝐾𝐴!" within the bacteriostatic term cannot be directly estimated from the MIC 
curves of tetracycline, as the concentration required to reduce growth rate by 
half may not result in the population density reducing by half after 24 hours 
growth. 𝐾𝑚𝑎𝑥!" for each strain was assumed to be equal to the maximum 
growth rate of the bacteria. 𝐾𝐴!"!" and Hill coefficient (𝑚) was estimated 
through fitting the simulated growth in monoculture to death curves keeping all 
other parameters static. Minimising RMSE and maximising R2 determined best 
predictions for fitted values. 
 
Parameter values for the hydrolysis of ampicillin where taken from literature 
estimations of plasmid encoded TEM-1 β-lactamase. The typical 𝐾!"# value 
associated with the inactivation of ampicillin by a single TEM-1 molecule is 
~1000 s-1 (Nikaido and Normark, 1987; Stojanoski et al., 2015; Zimmermann 
and Rosselet, 1977) with a 𝑘! value of 12.9 µg ml-1 (Nikaido and Normark, 
1987). To estimate 𝑉!"# per cell, an estimate of the number of β-lactamase 
molecules per cell is required; a previous study estimated that a high copy 
number plasmid with a MIC of 16 mg ml-1 had ~7300 TEM-1 molecules per cell, 
whereas a low copy number plasmid with an MIC of 4 mg ml-1 produced five 
times less TEM-1 molecules (Suvorov et al., 2007). The RK2 plasmid provides 
sufficient resistant to survive at 4 mg ml-1 of ampicillin, having an MIC of 
approximately 9 mg ml-1 (Fang and Helinski, 1991), therefore an intermediate 
value of ~4400 TEM molecules per cell was estimated, resulting in a 𝑉!"# of 
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9.2×10-6 µg h-1 cell-1. The starting conditions of simulations were chosen to 
reflect laboratory competition experiments, within an initial total cell density of 
5×105 cell ml-1. Models were iterated for a simulated 24 hours. Antibiotic was 
applied in a single dose at the start of the simulation and is simulated to be 
homogenously distributed throughout the environment. 
 
Using the fitted parameter values, the concentration of antibiotic required to 
select for resistance was predicted. Simulations were initiated with a 50:50 co-
culture of both sensitive and resistant sub-populations with a single dose of 
antibiotic. Mathematical solutions to the models were calculated over 24 hrs of 
growth, and the final density of both sub-populations were use to calculate the 
relative fitness of the resistant population using equation (4). This was 
conducted over a range of antibiotic concentrations to produce fitness reaction 
norms (Figure 3.2). These predicted fitness reaction norms were then compared 
to previously published, experimentally derived fitness reaction norms (Bottery 
et al., 2016). To account for the different MICs of the two antibiotics we 
examined the impact of antibiotic concentrations as percentage of sensitive 
bacteria’s MIC (% of 𝑆 MIC). 
 
 
3.4 Results 
 
3.4.1 Model fitting 
The parameters of the death terms were fitted to previously published MIC data 
(Bottery et al., 2016). Tetracycline was modelled to have a purely bacteriostatic 
effect; lowering the growth rate of cells. As the sufficient quantities of 
tetracycline were able to reduce all growth of both resistant and sensitive cells to 
zero (Figure S3.1 A/B), 𝐾𝑚𝑎𝑥!" was parameterised as the maximum achievable 
growth rate for each strain. Values for 𝐾𝐴!"!" were predicted through fitting to 
MIC curves (Figure S3.1A/B), the fit describes the MIC of resistant monoculture 
well, with a R2 value of 0.99 and RMSE of 0.03. However, the fit for sensitive 
cells over estimated the concentration of tetracycline required to have an effect 
on the population density, producing a poorer fit with a R2 value of 0.81 and 
RMSE of 0.12.  
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The parameter fit to the ampicillin sensitive MIC curve using a death term results 
in a high precision fit with a R2 value of 0.98 and RMSE of 0.04 (Figure S3.1 C). 
As the MIC of resistant cells was not determined it was not possible to fit the 
model to this curve (Figure S3.1 D), therefore the death rate was assumed to be 
equal to the parameterised value for sensitive cells under ampicillin treatment 
and the 𝐾𝐴!"!" term was estimated as a value that provides growth at 4 mg ml-1 
of ampicillin. With these values of 𝐾𝑚𝑎𝑥!" and 𝐾𝐴!"!" along with the ampicillin 
inactivation rate estimated form literature values, the resistant cells were 
predicted to have a MIC of 4800 µg ml-1. This is likely an underestimate of the 
level of resistance provide by the RK2 plasmid (Fang and Helinski, 1991), 
however the value of 𝐾𝐴!"!" had very little effect on the qualitative output of the 
mathematical model. β-lactamase accumulates within the periplasmic space of 
gram-negative bacteria (Bowden and Georgiou, 1990; Livermore, 1995); 
although some extracellular release may occur due to leakage, degradation of 
the antibiotic mostly occurs locally to the resistant cell and resistance is still 
primarily directed towards the resistant population.  Therefore, when the 
mechanism of resistance is through the inactivation of antibiotic, we assume 𝐾𝐴!"!" remains greater than 𝐾𝐴!"!", reflecting the decreased chance of the 
antibiotic molecule reaching its target. This acts to partly privatise the resistance 
to the resistant population, without adding further spatial complexity e.g. 
diffusion across the cell wall to the model. Without this privatisation (𝐾𝐴!"!" = 𝐾𝐴!"!"), inactivation of ampicillin alone at the parameterised rates would 
provide resistance to 46 µg ml-1 ampicillin. Under the assumption of 𝐾𝐴!"!" = 𝐾𝐴!"!", resistance would be completely communal, providing equal benefit to 
both resistant and sensitive bacterial sub-populations. 
 
3.4.2 Antibiotic Resistance Selection Reaction Norms 
Tetracycline resistance is modelled purely with an increased 𝐾𝐴!"!" reflecting 
the complete privatisation of resistance encoded via an efflux pump on the RK2 
plasmid. This results in the bacterial population having no influence on the 
concentration of antibiotic within the system. Whereas, ampicillin resistance also 
included an inactivation term, reducing the global concentration of antibiotic 
based on the population size of 𝑅. The difference in resistance mechanism 
resulted in different relative concentrations of antibiotic being required to select 
for resistance (Figure 3.2).  The model accurately predicted the fitness reaction 
norm when the RK2 plasmid was under tetracycline selection with a R2 fit of 
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0.92.  Just 1% of the sensitive MIC of tetracycline (20 ng ml-1) was required to 
select for resistance.  
 
 
 
Figure 3.2 | Simulated relative fitness of plasmid carriage, calculated from the 
numerical solution to models (1)-(3), of resistant population (𝑅) after 24 hr 
growth in competition with sensitive bacteria (𝑆) starting at equal densities. 
Simulations were initiated with increasing antibiotic (𝐴) concentrations of A 
tetracycline or B ampicillin. Dotted line in panel B represents simulated relative 
fitness of 𝑅 when there is no cooperative inactivation of antibiotic by the 𝑅 sub-
population (𝑉!"# = 0). Concentration of antibiotic is labelled as a percentage of 𝑆 MIC (tetracycline 2 µg ml-1 and ampicillin 9 µg ml-1). Horizontal black line 
represents equal fitness between 𝑅 and 𝑆 (relative fitness = 1), vertical dashed 
lines show the models prediction of the intercept of 1, and the vertical solid line 
shows the experimentally determined intercept of 1. 
 
 
The models fit to the ampicillin fitness reaction norm was less accurate, it did not 
capture the plateau in plasmid cost at low concentrations of ampicillin observed 
in the experimental data, and underestimated the concentration of ampicillin 
required to select for resistance, resulting in a R2 of 0.67. This less accurate fit 
reflects the increased complexity of the ampicillin model, and may be due to 
inaccurate parameterisation of either the inactivation rate of ampicillin, or the 
parameterised death curve not reflecting the true dynamics in co-culture. An 
inactivation rate of 1.52 × 105 (approximately 7300 beta-lactamase molecules 
per cell, similar to high copy number TEM-1 encoding plasmids (Suvorov et al., 
2007)) was required to produce the same relative fitness intercept of 1 as the 
experimental data, but the shape of the curve did not reflect the data, having an 
poorer R2 fit of 0.58. Increasing the Hill coefficient while maintaining the same 
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MIC (𝐾𝐴!"!" = 6.2, 𝐾𝑚𝑎𝑥!" = 1.6, 𝑛 = 6) produced an improved R2 fit of 0.82 
(Figure 3.3). However, the originally parameterised model still predicts a much 
higher relative concentration of ampicillin is required to select for resistance, 
77% of the sensitive MIC (6.9 µg ml-1), with co-culture allowing positive growth 
of sensitive cells beyond their MIC. When the inactivation rate is set to zero 
within the model, the concentration of ampicillin required to select for resistance 
is reduced to 8% of the sensitive MIC, confirming that the inactivation of 
ampicillin is providing the protection to sensitive bacteria (Figure 3.2 B). 
 
 
 
Figure 3.3 | Best simulated fit to experimental relative fitness of 𝑅 when in 
competition with 𝑆 across ampicillin concentration gradient. Horizontal black line 
represents equal fitness between 𝑅 and 𝑆, vertical solid line shows the 
experimentally observed intercept of 1. Model parameters: 𝐾𝐴!"!" = 6.2, 𝐾𝑚𝑎𝑥!" = 1.6, 𝑛 = 6. 
 
 
Treatment with tetracycline provides a constant positive selective pressure for 
resistance throughout logistic growth (Figure 3.4A), as the environmental 
concentration of antibiotic remains unchanged (Figure 3.4B). Tetracycline has 
no effect after the population reaches 𝐾, resulting in a linear fitness reaction 
norm with very low levels of antibiotic required to overcome the cost of 
resistance. In contrast, the population dynamics resulting from ampicillin 
selection are more complex. Upon inoculation there is strong selection for 
resistance while the concentration of antibiotic is high (Figure 3.4C). This 
increases the frequency of resistance within the population, but also increases 
the effective inactivation rate of ampicillin, resulting in a lower environmental 
concentration of antibiotic (Figure 3.4D). This phenomenon scales with the initial 
concentration of antibiotic, meaning that the higher the initial concentration of 
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ampicillin, the stronger the selection for resistance, resulting in faster 
inactivation of the antibiotic. The reduction in the environmental concentration of 
ampicillin allows the reinvasion of sensitive cells back into the population. 
However, as ampicillin is a bactericidal, reinvasion can only occur so long as the 
initial transient selection is not strong enough to cause the extinction of the 
sensitive sub-population. Reinvasion is also limited by the rate of inactivation of 
the antibiotic, and can only occur when ampicillin is inactivated to sufficient 
levels before the population reaches 𝐾.  
 
 
 
Figure 3.4 | Simulated population dynamics predicted from numerical solutions 
of models (1) – (3) presented in Figure 3.3. Panels A and C show change 
frequency of 𝑅 through time in response to antibiotic selection. Panels B and D 
show change in frequency of 𝑅 plotted against antibiotic concentration. Arrows 
are located every hour for the first three hours, indicating the passage of time for 
each simulation. Line colour represents the starting concentration of antibiotic 
used within each simulation. Points show the final frequency of 𝑅 at t = 24 hr.  
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To test the predictive power of the model we went on to predict the fitness 
surface in response to co-treatment with both ampicillin and tetracycline. The 
model confirms the empirical results found by Bottery et al. (2016)  showing 
treatment with tetracycline can mask the benefits of the social resistance 
mechanism, causing lower concentration of both ampicillin and tetracycline to 
select for resistance (Figure 3.5). 
 
 
 
Figure 3.5 | Simulated relative fitness of 𝑅 under combinatorial selection with 
both ampicillin and tetracycline. Black line shows intercept of 1 (equal fitness). 
Relative fitness of 0.9, 1.1, 1.2 and 1.3 labelled in grey.  
 
 
3.4.3 Frequency dependence 
It is expected that the relative fitness of non-cooperating cheaters within a 
microbial population will be greater when rare (Dugatkin et al., 2005; Ellis et al., 
2007; Ross-Gillespie et al., 2007). Experimental data shows that selection for 
ampicillin resistance mediated by a β-lactamase is negatively frequency 
dependent (Chapter 2, section 2.4.3, Figure 2.4). In contrast, selection for 
tetracycline resistance encoded by an efflux pump is not frequency dependent 
(Chapter 2, section 2.4.3, Figure 2.4). 
 
Consistent with previous findings, the model predicts that selection for 
tetracycline resistance via efflux is not frequency dependent (Figure 3.6B). The 
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concentration of tetracycline required to select for resistance remained at 1% of 
the sensitive MIC, independent of the initial frequency of resistant cells within 
the population. In contrast, the selection for ampicillin resistance showed 
negative frequency dependence (Figure 3.6A). When resistance is rare within a 
population approximately 25% of the sensitive MIC is required to select for 
resistance, whereas, then sensitive cells are rare over 100% of the sensitive 
MIC is required to select for resistance. The survival of sensitive cells is 
dependent upon the frequency of resistant cells within the population when 
under ampicillin treatment. When resistance is rare, the effective inactivation 
rate is low, resulting in more continuous selection for resistance. The extent that 
frequency alters the selection conditions may be dependent upon the 
localisation of the benefit produced; it is expected that frequency dependence 
would be favoured when the public good is preferentially directed towards the 
co-operators (Ross-Gillespie et al., 2007). In the case of ampicillin resistance, 
preferential access to resistance is provided by the localisation of the β-
lactamase in the periplasm of resistant cells, is reflected in the model by partial 
privatisation of resistance (𝐾𝐴!"!" >  𝐾𝐴!"!").  
 
 
 
Figure 3.6 | Simulated relative fitness of 𝑅 with varying antibiotic concentration 
(A ampicillin and B tetracycline) and starting frequency of 𝑅 (starting 𝑅 from 
0.01 to 0.99). Black line shows intercept of 1 (equal fitness). Relative fitness of 
0.9, 1.1, 1.2 and 1.3 labelled in grey.  
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3.4.4 Predicting the interaction between mode of antibiotic action and 
mechanism of resistance 
The results show that inclusion of the mechanism of resistance, whether the 
antibiotic is inactivated by the resistant population or not, is required to 
accurately predict the selection of resistance. We now examine the potential 
interaction between the mechanisms of resistance and the mode of antibiotic 
action. By determining the fitness landscape of resistance across hypothetical 
inactivation rates for ampicillin and tetracycline we can predict how the mode of 
action of the antibiotic affects the selection of resistance. Figure 3.7 shows the 
effect of varying inactivation rate of ampicillin on the relative fitness of the 
resistance sub-population. A higher inactivation rate results in higher 
concentrations of ampicillin required to select for resistance, but this effect 
becomes saturated, with less gain as the inactivation rate increases. However, 
the dynamics of selection with cooperative inactivation of a bacteriostatic, such 
as tetracycline, differ greatly from those of the bactericidal (Figure 3.8). 
Increasing the inactivation rate of tetracycline provides an increasing benefit for 
sensitive cells. Cooperative resistance may therefore be more beneficial when 
the antibiotic target is a bacteriostatic rather than a bactericidal.  
 
 
 
 
Figure 3.7 | Simulated relative fitness of 𝑅 with varying ampicillin concentration 
and inactivation rate. 𝑉!"# = 0 Is omitted from plot and is presented in Figure 
3.4B. Black line shows intercept of 1 (equal fitness). 
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Figure 3.8 | Simulated relative fitness of 𝑅 with varying tetracycline 
concentration and inactivation rate. 𝑉!"# = 0 Is omitted from plot and is 
presented in Figure 3.3A. Black line shows intercept of 1 (equal fitness). 
 
 
3.5 Discussion 
 
PK-PD models are commonly used to predict the outcome of drug treatments in 
order to optimise the clinical effectiveness of antibiotic regimens (Chung et al., 
2006; Czock and Keller, 2007; Mouton et al., 1997). These models often have 
simple approximations of mechanism of resistance and action of antibiotics. 
However, recent studies have shown that biological details, such as the 
mechanism of resistance and mode of action of antibiotic, can alter the selective 
conditions of resistance (Bottery et al., 2016; Sorg et al., 2016; Yurtsev et al., 
2013), aspects which are often overlooked in PK-PD models. Here we show 
that, without an accurate representation of these details of antibiotic resistance, 
the effectiveness of PK-PD models, when used to predict the evolution of 
resistance, is limited.  
 
We presented a model of bacterial population dynamics that incorporated terms 
describing both the mechanism of resistance and mode of action of antibiotics, 
allowing the distinction of bacteriostatic and bactericidal antibiotics as well as 
resistance mechanisms that do and don’t inactivate antibiotics. Through the 
inclusion of these terms, our models can more accurately predict the antibiotic 
concentrations required to select for resistance. Firstly, the inactivation of 
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antibiotics by a resistant sub-population can allow sensitive cells to survive at 
concentrations of antibiotic alone would usually kill them. These results can only 
be reliably replicated through the inclusion of antibiotic inactivation terms within 
a model, as the rapid inactivation of antibiotic within an environment by resistant 
cells is the driving factor shaping the selection of resistance. Secondly, the 
model accurately predicts that the mechanism of resistance alters the frequency 
dependence of selection. The predictions of the model are consistent with 
experimental data showing that the selection for bacteria harbouring resistance 
mechanisms that do not alter the environmental concentration of antibiotic, such 
as efflux pumps, is independent from the frequency of resistant bacteria within 
the population. Whereas, resistances that inactivate antibiotics, such as β-
lactamases, are negative frequency dependent; i.e. selection for resistant 
bacteria is stronger when they are rare.  
 
Given the models strong predictive power of the social interaction mediated by 
antibiotic resistance mechanism, we sought to explore the theoretical interaction 
between mode of antibiotic action and mechanism of resistance. The model 
predicts that these properties interact; whereby, inactivation of bacteriostatic 
antibiotics by resistant bacteria provides greater protection to sensitive bacteria 
within a population than the inactivation of bactericidal antibiotics. As 
bacteriostatic antibiotics simply reduce the growth rate of sensitive cells, they 
are initially out grown by the resistant population rather than being actively killed 
as would be the case when under selection by a bactericidal antibiotic. This 
results in a more effective reinvasion of sensitive cells once the antibiotic it is 
cleared from the environment. Thus, the model provides a testable hypothesis 
that mode of action of an antibiotic influences the invasion of resistance within 
bacterial populations, and may help to explain the rarity of resistance 
mechanisms that inactivate tetracycline (Forsberg et al., 2015).  
 
The proposed model has limitations, the effect of antibiotics upon bacteria are 
not purely bacteriostatic, or bactericidal, and are often weighted combinations of 
the two or concentration dependent. More accurate parameterisation of the 
weightings of a specific antibiotic towards the –static or –cidal terms can be 
achieved by fitting to time course data. However, data presented here suggests 
that fitting pure –static or –cidal terms to MIC curves provide an adequate 
approximation allowing the accurate prediction of social dynamics upon the 
selection of resistance. We use tetracycline and ampicillin ARGs as examples, 
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but the model in not specific to these antibiotics or resistance mechanisms, and 
can be applied to any antibiotic. Despite these limitations, our model shows that 
a systematic understanding of the nature of the action of existing antibiotics and 
their resistance mechanisms is needed to permit reliable mathematical 
modelling of the impact of AMR. 
 
The model highlights that the mode of antibiotic action and resistance can have 
major implications on the evolutionary and ecological outcomes of antibiotic 
selection. To accurately predict the selection and maintenance of resistance 
within a bacterial population, whether encoded on a MDR plasmid or 
chromosomally, a clear understanding of the sociality of resistance and impact 
of antibiotic mode of action are required. 	 	
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4. Adaptive Modulation of Antibiotic Resistance Through 
Intragenomic Coevolution 
 
The following chapter has been published as: Bottery, M.J., Wood, A.J., and 
Brockhurst, M.A. (2017). Adaptive modulation of antibiotic resistance through 
intragenomic coevolution. Nat. Ecol. Evol. 1, 1364–1369. M.A.B. and A.J.W. 
supervised the project. M.J.B. performed the experiments and analysed the 
data. All authors contributed towards the design of the study and wrote the 
manuscript. 
 
4.1 Abstract 
Bacteria gain antibiotic resistance genes by horizontal acquisition of mobile 
genetic elements (MGE) from other lineages. Newly acquired MGEs are often 
poorly adapted causing intragenomic conflicts, resolved by compensatory 
adaptation of the chromosome, the MGE or reciprocal coadaptation. The 
footprints of such intragenomic coevolution are present in bacterial genomes, 
suggesting an important role promoting genomic integration of horizontally 
acquired genes, but direct experimental evidence of the process is limited. Here 
we show adaptive modulation of tetracycline resistance via intragenomic 
coevolution between Escherichia coli and the multi-drug resistant (MDR) 
plasmid RK2. Tetracycline treatments, including monotherapy or combination 
therapies with ampicillin, favoured de novo chromosomal resistance mutations 
coupled with mutations on RK2 impairing the plasmid-encoded tetracycline 
efflux-pump. These mutations together provided increased tetracycline 
resistance at reduced cost. Additionally, the chromosomal resistance mutations 
conferred cross-resistance to chloramphenicol. Reciprocal coadaptation was not 
observed under ampicillin-only or no antibiotic selection. Intragenomic 
coevolution can create genomes comprised of multiple replicons that together 
provide high-level, low-cost resistance, but the resulting co-dependence may 
limit the spread of co-adapted MGEs to other lineages.   
 
 
4.2 Introduction 
 
Horizontal gene transfer (HGT) is a fundamental process in bacterial evolution 
that accelerates adaptation by sharing ecologically important accessory traits 
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between lineages (Jain et al., 2003). These accessory traits are themselves 
frequently located on semi-autonomous mobile genetic elements (MGE), such 
as conjugative plasmids, that encode genes for their own replication, partition 
and horizontal transfer (Frost et al., 2005; Norman et al., 2009). Conjugative 
multidrug resistance (MDR) plasmids, encoding antibiotic resistance genes 
(ARGs) against multiple classes of antibiotics, are of particular clinical concern 
since they allow instantaneous acquisition of MDR phenotypes and thus 
potentiate the rapid emergence of MDR bacterial pathogens (Carattoli, 2013; 
Svara and Rankin, 2011). Newly acquired conjugative plasmids are often costly 
since the plasmid is unlikely to be well adapted to the new genetic background, 
causing intragenomic conflict (Baltrus, 2013). The cost of plasmid carriage is 
likely to arise due to the metabolic burden of maintaining, transcribing and 
translating plasmid genes (Diaz Ricci and Hernández, 2000), as well as via 
disruption of cellular homeostasis caused by gene regulatory interference 
between chromosomal and plasmid regulators (Harrison et al., 2015; San Millan 
et al., 2015), and cytotoxic effects of plasmid gene products (Baltrus, 2013).  
 
An important route to resolving this intragenomic conflict is compensatory 
evolution to ameliorate the cost of plasmid acquisition (Harrison and Brockhurst, 
2012). Experimental evolution suggests that compensatory evolution can arise 
via mutations located on either the chromosome or the plasmid, or via 
intragenomic coevolution involving both plasmid and chromosome mutations 
(Harrison et al., 2015; Loftie-Eaton et al., 2016; Porse et al., 2016; San Millan et 
al., 2015). Comparative genomics suggests a key role for compensatory 
evolution in natural bacterial populations, potentially stabilising MDR plasmids 
within lineages and thus allowing the evolutionary emergence by HGT of MDR 
pathogens (McNally et al., 2016). A key outstanding question is how the mode 
of compensatory evolution following MDR plasmid acquisition varies with 
antibiotic treatment. Here we experimentally evolved Escherichia coli MG1655 
carrying the MDR plasmid RK2 (encoding tetracycline and ampicillin resistance 
genes) under a range of antibiotic treatment regimes including no antibiotic, 
mono- and combination-therapies of tetracycline and ampicillin. Following 530 
generations of selection we quantified evolved changes in antibiotic resistance 
and fitness, and used genome sequencing to determine the genetic bases of the 
observed adaptation.  
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4.3 Methods 
 
4.3.1 Strains, culture conditions and evolution experiment 
E. coli MG1655 chromosomally labelled with GFP at the attB lambda attachment 
site was used in the evolution experiments. Isogenic E. coli MG1655-mCherry 
was used as a reference strain in competition experiments. Both E. coli strains 
were provided by the Van Der Woude lab (University of York). The RK2 plasmid 
was introduced to the strains through conjugation from E. coli MV10 provided by 
the Thomas lab (University of Birmingham). All cultures were grown in Oxoid® 
Nutrient Broth (NB) at 37°C 5 ml in 50 ml microcosms shaken at 180 rpm. 
Independent selection lines were founded by 30 independent single colonies of 
E. coli MG1655-GFP harbouring RK2. These were grown overnight in non-
selective conditions and split into the 5 antibiotic treatments, no antibiotic 
selection, 100 µg ml-1 ampicillin, 10 µg ml-1 tetracycline, 100 µg ml-1 ampicillin 
plus 10 µg ml-1 tetracycline, and 24 hour cycling between 100 µg ml-1 ampicillin 
and 10 µg ml-1 tetracycline, with 6 replicate populations per treatment. In 
parallel, 6 independent E. coli MG1655-GFP colonies were picked for control 
treatments and grown under no selection. Selection lines were established by 
transferring 50 µl of saturated overnight culture into 5 ml of selective media. 
These populations were maintained through transfer of 1% of the population into 
fresh media and antibiotics every 24 hours for 80 transfers, resulting in ~6.64 
generations per day, totalling ~530 bacterial generations. For the cycling 
treatment 3 populations were initiated with 100 µg ml-1 ampicillin and 3 
populations were initiated with 10 µg ml-1 tetracycline. Culture density (OD600) 
was recorded every 24 hours. Plasmid prevalence was measure at the start and 
end of the selection experiment by screening 20 randomly picked colonies from 
each population using multiplex primers specific to RK2 replication origin (Fw: 
ctcatctgtcaacgccgc, Rv: aaccggctatgtcgtgct), β-lactamase (Fw: 
ataactacgatacgggagggc, Rv: acatttccgtgtcgccctta), and tetracycline efflux pump 
(Fw: tgggttctctatatcgggcg, Rv: tgggcgagtgaatgcagaat). These primers allowed 
for the detection of plasmid loss and transposition of resistances onto the 
chromosome. One end point clone was randomly selected from each population 
for phenotypic typing, curing, calculation of MICs and sequencing. Every eight 
transfers throughout the experiment 500 µl samples of whole populations were 
collected and stored in 25% glycerol at -80°C. Whole populations were also 
plated out on non-selective media, 20 individual clones were then randomly 
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selected, sub-cultured for a further 24 hours in non-selective media, and stored 
in 25% glycerol in 96 well plates. 
 
4.3.2 Relative Fitness  
The relative fitness of the evolved plasmid bearing versus ancestral plasmid free 
strain was estimated by direct competition, with six replicate strains per-
treatment. The competitions were initiated with 50 µl of 1:1 mixtures of plasmid-
bearing evolved strain and plasmid-bearing ancestral strain marked with 
mCherry from overnight cultures in 5 ml of non-selective NB media. The relative 
fitness of the evolved strains was calculated by gaining exact viable cell counts 
at 0 hours and 24 hours, strains were distinguished through detection of 
fluorescent markers using Zeis Stereo Lumar v12 microscope. The relative 
fitness of plasmid-bearing bacteria was calculated as a ratio of Malthusian 
parameters (Crozat et al., 2005):  
𝑊!"# = ln 𝑁!"#$%,!"#𝑁!"!#$%,!"#
ln
𝑁!"#"$%,!"#𝑁!"!#!$%,!"#  
 
Fitness effects due to different markers was determined by competing plasmid 
free MG1655-GFP with plasmid free MG1655-mCherry, the relative fitness of 
MG1655-GFP was not significantly difference from 1 (t5=0.015584, p=0.9882) 
showing that there is no significant difference between the two marker strains. 
 
Relative fitness of evolved strains harbouring evolved plasmid or evolved strains 
harbouring ancestral plasmid versus ancestral plasmid bearing cells was 
estimated using the same method as above, with eighteen replicate strains per 
competition, but grown in 100 µl cultures in a 96 well plate, 37°C shaken at 600 
rpm, 3 mm orbital radius, inoculated to an initial dilution of 1:500. Again no 
fitness effect of markers was observed (t5=-0.2795, p=0.791). 
 
4.3.3 Curing RK2 from evolved strains 
Evolved strains were cured using the pCURE curing system (Hale et al., 2010). 
The anti-incP-1 cassette (RK2 oriV, parD, korA, and incC genes) from 
pCURE11 was ligated into the pLAZ2 chloramphenicol resistant vector that 
contains the sacB gene allowing counter selection for plasmid free segregants. 
The resultant plasmid was transformed into chemically competent evolved 
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strains and selected for using Cml 12.5 µg ml-1. Single colony transformants 
were re-streaked on to Cml 12.5 µg ml-1 plates and Cml 12.5 µg ml-1 + 5% 
sucrose. Sucrose sensitive colonies were checked by PCR for the presence of 
the curing plasmid (Fw: aagttttggtgactgcgctc, Rv: caaagacgatgtggtagccg) and 
absence of RK2 β-lactamase and tetA (primers as above). Successfully cured 
clones were cultured for 24 hours in non-selective media to allow segregation of 
the curing plasmid; sergeants were selected on antibiotic free, 5% sucrose 
plates. To confirm loss of both plasmids sucrose resistant colonies were 
checked for sensitivity to chloramphenicol, ampicillin, and tetracycline, as well 
as PCR using primers mentioned above. Both the ancestral strain harbouring 
RK2 and ancestral plasmid free strains under went the curing process and were 
used as a comparison to cured evolved strains to control for curing process. 
Ancestral RK2 was introduced into the cured evolved strains, and evolved RK2 
was introduced into the plasmid free ancestor through conjugation. Again, to 
control for the curing and conjugation steps, ancestral RK2 was conjugated into 
cured ancestral strains and used for comparison. Saturated overnight cultures of 
donor plasmid containing strains and recipient plasmid free strains were mixed 
1:1, and 50 µl was used to inoculate 5 ml NB. The mixed cultures were grown 
for 24 hours and plated out on to 100 µg ml-1 ampicillin to select for 
transconjugants. Transconjugants were confirmed by fluoresces and PCR 
screening for RK2 plasmid.  
 
4.3.4 Minimum inhibitory concentration 
To measure minimal inhibitory concentrations, six replicate cultures per-
treatment were grown overnight until stationary phase in 5 ml NB, the saturated 
cultures were then sub-cultured 50 µl into 5 ml fresh NB and grown to an OD600 
of 0.5. These were then diluted into 96-well plates containing a log2 serial 
dilution of antibiotic (AMP, TET or CML) to an initial density of 5×105 CFU ml-1. 
100 µl cultures were grown for 24 hours 37°C shaken at 600 rpm, 3 mm orbital 
radius. OD600 was measured after 24 hours. 
 
4.3.5 Growth Curves 
Six replicate saturated overnight cultures per-treatment were sub-cultured to an 
OD600 of 0.5, and used to inoculate 100 µl NB supplemented with 10 µg ml-1 TET 
per well in 96-well plates at a final dilution of 1:1000. Plates were grown at 37°C 
with shaking at 300 rpm, 3 mm orbital radius for 24 hours, OD600 was measured 
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every 16 minutes by Tecan infinite M200 Pro plate reader. Growth rates were 
calculated as the maximum slope of log2 transformed OD600 covering four time 
points (~1 hour of growth), lag phase was calculated to end when growth rate 
reached 10% of the maximum achieved growth rate. 
 
4.3.6 Genome sequencing and analysis 
Whole genomes were extracted from each evolved population’s clone as well as 
the ancestral strain and ancestral strain harbouring the RK2 plasmid using the 
DNeasy Blood and Tissue extraction kit (Qiagen). The total DNA was 
sequenced by MicrobesNG (http://www.microbesng.uk), which is supported by 
the BBSRC (grant number BB/L024209/1), using Illumnia MiSeq. Reads were 
mapped to E. coli MG1655 K-12 genome (GenBank accession U00096.3) and 
RK2 (GenBank accession BN000925.1) reference using BWA-MEM (Li and 
Durbin, 2009). Single nucleotide variants and small indel events were detected 
using GATK UnifiedGenotyper (McKenna et al., 2010) and SnpEff (Cingolani et 
al., 2012), insertion sequences were identified using custom scripts and 
Integrative Genomics Viewer (Robinson et al., 2011), and large genome-wide 
structural variants were detected using BreakDancer (Chen et al., 2009). 
Mutations that were present in the ancestral clones were excluded, resulting in a 
set of mutations that were acquired during the selection experiment. 
 
4.3.7 Tracking mutations 
Populations that did not show a hypermutator phenotype, had insertion 
sequences within ompF, and mutations in the tetracycline resistance genes on 
the plasmid, from the constant TET treatments (T and AT treatments) were 
selected for further analysis to gain an understanding of the mutational timeline 
during the selection experiment. Insertion sequences within ompF were 
identified within whole populations of T4, AT2, AT3 and AT5 by PCR of the 
ompF gene (Fw: ACTTCAGACCAGTAGCCCAC, Rv: 
GCGCAATATTCTGGCAGTGA). A short product of 716 bp indicated no 
insertion sequence, a long product of 1484 bp indicted IS1 and a long product of 
1911 bp indicted IS5. Whole population PCR indicated that ompF::IS mutants 
had swept into the population by transfer 40 for populations T4, AT2 and AT5, 
and transfer 48 in population AT3. Frequency of ompF insertion sequences 
were calculated by PCR of 20 clones from transfers 8, 16, 24, 32, and 40. 
Tetracycline resistance genes (tetA and tetR) from clones containing ompF::IS 
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mutations from population AT2, transfers 8, 16, 24, and 32 were then Sanger 
sequenced to determine if ompF mutations arise before tetAR mutations (tetA: 
Fw: GGCTGCAACTTTGTCATG, Rv: TTCCAACCGCACTCCTAG, Internal1: 
ACAGCGCCTTTCCTTTG, Interal2: AAGGCAAGCAGGATGTAG; tetR: Fw: 
TCTGACGCGGTGGAAAG, Rv: ACGCGCGGATTCTTTATC, Internal1: 
GAGCCTGTTCAACGGTG, Internal2: TCTGACGACACGCAAAC). 
 
4.3.8 Statistical analysis 
To test if the mutations observed within each treatment had significantly different 
variances a multivariate homogeneity of groups variances test was conducted 
(Anderson, 2006). The binary presence or absence of a variant at each allele 
was use to calculate a Euclidean distance matrix between each population. This 
was used to test for homogeneity of variances between treatments using 
betadisper {vegan 2.4-0}. The variances between treatments were significantly 
different, with hypermutators significantly affecting within-group variation. These 
clones were removed from further analysis as significant differences in within-
group variance can lead to falsely significant results when testing for differences 
between groups (Anderson, 2001). Permutational Multivariate Analysis of 
Variance was used to calculate whether different evolutionary treatments 
resulted in different sets of mutations (Anderson, 2001; Zapala and Schork, 
2006). Using the Euclidean distance matrix with hypermutators removed, the 
significance of within- and between-group distances was calculated using 
adonis2 {vegan 2.4-0}. The data was partitioned into different groups, multiple 
testing was corrected for using Bonferroni correction. Neighbour Joining 
phylogeny was constructed using the binary presence or absence table with 
hypermutators removed. Tree estimation and bootstrap support was conducted 
using ape-package {ape 4.0}. Significant difference between two related 
samples was calculated using two sided, two-sample t-test. Shapiro-Wilk test 
was conducted to check for normality, when normality could not be assumed a 
non-parametric Wilcoxon signed-rank test was used. Differences among 
treatments growth under antibiotic selection were calculated by ANOVA of the 
integral of the resistance profiles, with subsequent Tukey multiple comparison of 
means. All statistical analysis was conducted in R (version 3.2.3). 
 
 
 
	 73 
4.3.9 Data Availability 
The sequence data supporting the findings of this study are available at the 
European Nucleotide Archive, accession: PRJEB20735. All other data in this 
study is available at Figshare data depository 
(https://doi.org/10.6084/m9.figshare.5092225.v1). Custom code used to map 
possible IS elements are available online 
(https://github.com/mbottery/Co_Evo_IS_Analysis). 
 
 
4.4 Results 
 
Thirty independent isogenic populations of E. coli MG1655 carrying the MDR 
plasmid RK2 (Pansegrau et al., 1994), which encodes resistances to 
tetracycline (TET) and ampicillin (AMP), were experimentally evolved for ~530 
generations (80 days), under five antibiotic treatments (six independently 
evolving lines per treatment): no antibiotic (N), AMP (A), TET (T), AMP plus TET 
(AT), and 24 hour cycling between AMP and TET (A/T) (see methods). Plasmids 
remained at high frequency in all populations for the duration of the selection 
experiment. Plasmid-free segregants were only observed at very low frequency 
in two of the six populations from treatment N (Figure S4.1), whereas 
transposition of resistance genes from RK2 onto the host’s chromosome was 
never observed.  
 
To test for changes in antibiotic resistance profiles following evolution we first 
determined the minimum inhibitory concentration (MIC) of evolved lineages to 
TET and AMP. The susceptibility of the evolved strains to antibiotics differed 
between treatments (Figure 4.1A). We observed a four-fold increase in TET MIC 
in evolved strains from the T and AT treatments and a small increase in lineages 
that had evolved under the cycling A/T treatment compared with the ancestral 
MG1655 with ancestral RK2 (Anc-RK2), whereas evolved strains from 
treatments N and A showed no change in tetracycline MIC (ANOVA, F5,30 = 
6.103, p < 0.001; Post-hoc Tukey Tests, Anc-RK2:T p < 0.001, Anc-RK2:AT p < 
0.01, Anc-RK2:N p = 0.525, Anc-RK2:A p = 0.783). By contrast, we observed no 
change in resistance to AMP in any treatment (ANOVA, F5,30 = 1.212, p = 
0.327), possibly due to a lower relative selection pressure imposed by the 
concentration of AMP used in the experiment compared to the concentration of  
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Figure 4.1 | Resistance profiles of evolved plasmids and hosts. Growth of a, 
evolved MG1655 strains with evolved RK2 plasmids b, evolved MG1655 strains 
cured of evolved RK2 plasmids c, evolved MG1655 strains with ancestral RK2 
plasmid and d, ancestral MG1655 clones with evolved RK2 plasmids in the 
presence of tetracycline, ampicillin or chloramphenicol in comparison to 
ancestral MG1655. Points represent means of one clone from each of the six 
independent treatment populations, with SEM error bars. Dashed grey and black 
lines show the resistance profiles of plasmid free and plasmid containing 
ancestral strains respectively. Dashed lines in evolved host cured of plasmid 
plots (c) show ancestral MG1655 and ancestral MG1655(RK2) after curing 
process. Dashed lines in ancestral host evolved plasmid plots (d) show 
ancestral MG1655 and ancestral MG1655(RK2) which had under gone curing 
with ancestral RK2 subsequently reintroduced.  Vertical dashed lines in AMP 
and TET resistance profiles show the concentrations of AMP (100 µg ml-1) or 
TET (10 µg ml-1) used in the selection experiment. 
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TET (Bottery et al., 2016). Interestingly, TET selection led to the evolution of 
bacteria that were cross-resistant to chloramphenicol (CML), although the extent 
of the evolved cross-resistance varied between treatments (ANOVA, F5,30 = 
24.25, p < 0.001); with CML MIC increasing 8-, 4-, and 2-fold in T, AT, A/T 
treatments, respectively. Consistent with CML cross-resistance being a 
correlated response to TET selection, evolved strains from both the N and A 
treatments remained equally sensitive to CML as the ancestral MG1655(RK2) 
(Post-hoc Tukey Tests, Anc-RK2:N p = 0.975, Anc-RK2:A p = 0.993). Thus 
whereas T and AT treatments, and to a lesser extent the cycling A/T treatment, 
led to the evolution increased TET resistance and cross-resistance to CML, 
evolved lineages from the N and A treatments showed no change in their 
resistance profile. 
 
To examine the genetic bases of evolved changes in resistance we next 
obtained whole genome sequences for one randomly selected clone per 
population. Excluding hypermutators, evolved clones had acquired between 2 
and 11 mutations, located exclusively on the chromosome in non-TET 
treatments (C, N, A), and on both the chromosome and plasmid in the 
treatments including TET (T, AT, A/T) (Figure S4.2). Of all the observed 
mutations 13.2% were synonymous and 19% were intergenic, the remaining 
non-synonymous mutations (67.8%) comprised missense mutations (42.8%), 
frameshifts (10.6%), insertion sequences (5.6%) and gene deletions (5.4%), and 
these were analysed further. While the variance in the number of non-
synonymous mutations did not differ between treatments (Analysis of 
multivariate homogeneity of group variances excluding hypermutators F5,26 = 
1.8617, p = 0.1358), the loci affected by non-synonymous mutations did vary 
between treatments (Permutational ANOVA, permutation test: F5,26 = 2.5231, p 
< 0.01, Bonferroni corrected). Clones that had evolved under TET selection (T, 
AT, A/T) had significantly different sets of non-synonymous mutations compared 
to evolved clones from the other treatments (C, N, A) (permutation test: F1,30 = 
6.9463, p < 0.01, Bonferroni corrected), with a larger genetic distance between 
TET and non-TET treatments than within these treatment groups (Figure 4.2A). 
Thus TET-selected lineages followed an evolutionary trajectory distinct from 
non-TET-selected lineages, leading to mutations on both the chromosome and 
the plasmid, which suggest that TET selection favoured bacteria-plasmid 
coadaptation. 
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Figure 2 | Mutations show treatment specific parallelism. a, An unrooted 
neighbour joining phylogeny of end-point evolved clones. The distance matrix 
was constructed from the binary presence or absence of variants at each gene 
relative to the ancestral strain; hypermutators were excluded from the analysis. 
Scale bar represents number of gene variants; percentage bootstrap support is 
shown at the branches, B=1000, values below 0.3 are omitted. Blue branches 
represent clone isolated from TET treatments. b, Mutations observed in evolved 
clones (excluding hypermutators) across treatment. Rings represent E. coli 
chromosomes or RK2 plasmids. Dots represent mutations, the size of the dots 
represent the number of mutations at the same loci across independent 
replicate populations. Plots of individual treatments are in Figure S4.3.  
 
 
Strikingly parallel mutations were observed between independent replicate 
populations both within and between TET-containing treatments (Figure 4.2B). 
Highly parallel mutations are likely to represent adaptive evolution at these loci, 
and because mutations at these loci were not observed in the populations from 
the N and A treatments, these mutations were likely to be TET-specific 
adaptations. Mutations in the chromosomal genes ompF (16 out of 18 clones), 
and ychH (16 out of 18 clones) showed strong locus-level parallelism within all 
three TET-containing treatments. Mutations in ompF, encoding a major non-
specific diffusion porin (Cowan et al., 1992), were all predicted loss-of-function 
mutations, including the insertion of IS elements, frameshifts or premature stop 
codons. The loss of OmpF in E. coli reduces membrane permeability, including 
to antibiotics, and consequently is known to increase resistance to a wide 
spectrum of antibiotics (Blair et al., 2015) including TET and CML (Cohen et al., 
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1989; Thanassi et al., 1995). Deletion of ompF (E. coli K-12 ΔompF JW0912 
(Baba et al., 2006)) significantly increased resistance to TET without the RK2 
(t9.09 = 4.2836, p < 0.01), and further increased TET resistance when carrying 
RK2 (Two-way ANOVA Interaction F1,20 = 14.724, p < 0.01; Figure S4.4A). 
Parallel loss of function mutations (IS elements and frameshifts) in ychH were 
observed across all the TET treatments. YchH is a hypothetical stress-induced 
inner membrane protein (Lee et al., 2010; Mendoza-Vargas et al., 2009), but 
deletion of ychH (E. coli K-12 ΔychH JW1196 (Baba et al., 2006)) did not 
significantly increase the resistance to TET with or without the plasmid (Figure 
S4.4B), suggesting that this general stress response may not be required under 
TET selection and is consequently selected against.  
 
Mutations in several loci observed in the T and AT treatments were not present 
in the cycling A/T treatment. These included mutations in both acrR (10 out of 
12 clones) and adhE (9 out of 12 clones). Mutations in adhE were extensively 
parallel at the nucleotide level, with 8 clones from independent populations all 
having the same missense SNP in the ethanol dehydrogenase domain 
(Membrillo-Hernández et al., 2000). The phenotypic significance of these 
mutations is unclear due to the multiple roles assigned to this protein, including 
multiple metabolic pathways (Kessler et al., 1991), but intriguingly the AdhE 
protein is known to exhibit binding activity to the 30S ribosome (Shasmal et al., 
2016), the primary TET target. The acrR gene encodes a repressor of AcrAB 
multidrug efflux pump (Ma et al., 1996), the majority of mutations in acrR are 
predicted loss of function mutations, with IS elements and frameshifts observed 
in evolved strains. The deletion of acrR results in the overexpression of acrAB 
leading to MDR phenotypes (Okusu et al., 1996; Wang et al., 2001). Deletion of 
acrR (E. coli K-12 ΔacrR JW0453 (Baba et al., 2006)) alone did not significantly 
increase resistance to TET (t9.32 = -0.591, p = 0.339), but when combined with 
the RK2 plasmid did allow significantly increased growth in TET (t6.4 = 3.665, p < 
0.01, Figure S4.4C). These findings are consistent with the higher TET 
resistance of evolved clones from the T and AT treatments versus the A/T 
treatment (Figure 4.1A) and reflect overall weaker TET selection under the A/T 
cycling compared to the T and AT treatments where TET selection was 
constant. Interestingly, stronger TET selection appeared to constrain evolution 
at chromosomal loci not involved in resistance. For example, we observed 
highly parallel loss of function mutation in the flagellum operon in the A, N and 
A/T treatments, but only rarely observed mutations at these loci in T and AT 
	 78 
treatments. Loss of the flagellar motility is a commonly observed adaptation of 
E. coli to growth in liquid media (Cooper et al., 2003) and this may have been 
impeded by clonal interference or negative epistasis with chromosomal 
resistance mutations in populations under strong TET selection. Consistent with 
this, whereas evolved clones from the N and A treatments increased in fitness 
relative to the plasmid-free ancestor in antibiotic-free media, such fitness gains 
were not observed in evolved clones from the TET-containing treatments 
(Figure S4.5). 
 
To confirm that TET selection had led to the evolution of chromosomal 
resistance we next cured evolved strains of their plasmids and quantified 
resistance (Hale et al., 2010).. Evolved strains carrying putative chromosomal 
resistance mutations displayed increased TET (ANOVA, F5,30 = 42.63, p < 
0.001), AMP (ANOVA, F5,30 = 12.55, p < 0.001) and CML (ANOVA, F5,30 = 35.88, 
p < 0.001) resistance (Figure 4.1B). Across all tested antibiotics, evolved clones 
carrying both ompF and acrR mutations had significantly increased resistance 
compared to the ancestral MG1655 (Post-hoc Tukey Tests, all p < 0.05), 
whereas cured evolved strains without either of these mutations (i.e. from the N 
and A treatments) did not (Post-hoc Tukey Tests, all p > 0.05). Interestingly, 
cured evolved clones from the cycling A/T treatment that carried only mutations 
in ompF but not in acrR showed marginally increased resistance to both TET 
and CML, but no detectable increase in AMP resistance, relative to MG1655. 
Thus TET selection favoured the de novo evolution of chromosomal resistance 
despite pre-existing plasmid-encoded TET resistance, and these chromosomal 
resistance mutations are responsible for the observed cross-resistance to CML.  
 
We observed parallel mutations on the plasmid exclusively in evolved clones 
from the TET-containing treatments (T, AT, and A/T). These mutations occurred 
in tetA/tetR (18 out of 18 clones; tetA: 13, tetR: 2, both: 3, Figure 4.2B) which 
encode the tetracycline-specific efflux pump. The expression tetA is tightly 
regulated by the repressor tetR in the absence of tetracycline (Møller et al., 
2016; Ramos et al., 2005). Mutations in tetA were dispersed throughout the 
gene, affecting the protein’s transmembrane, periplasmic and cytoplasmic 
domains (Allard and Bertrand, 1992). Three of the five mutations observed in 
tetR are in direct contact with or in close proximity to the tetracycline binding 
pocket (Orth et al., 2000), while the other two mutations are located in the 
central scaffolding of the protein, suggesting that they are likely to interfere with 
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activity of the tetR repressor. Evolved plasmids carrying mutations in tetA or 
tetR displayed reduced resistance to TET in the ancestral MG1655 background 
compared to ancestral RK2 (Figure 4.1D, ANOVA, F5,30 = 4.586, p < 0.01). 
Consistent with reduced efficacy of plasmid-encoded resistance in evolved 
lineages with tetA/tetR mutations, when we replaced the evolved plasmid with 
ancestral RK2, this led to increased TET resistance (ANOVA, F5,30 = 71.86, p < 
0.001, Anc-RK2:T,AT,A/T all p < 0.05).  
 
Our data suggest that evolved strains from TET-containing treatments adapted 
their resistance to TET by acquisition of weak chromosomal resistance 
mutations in combination with mutations that reduced the efficacy of the 
plasmid-encoded TET efflux pump. To understand the evolutionary benefits of 
this counterintuitive dual resistance strategy we first compared the effect of 
chromosomal background (evolved or ancestral) and plasmid genotype (evolved 
or ancestral) on growth in the presence of 10 µg/ml TET (i.e., the concentration 
used in our selection experiment). The evolved chromosomal background 
carrying resistance mutations displayed a significantly shortened lag phase 
compared to the ancestral chromosomal background, irrespective of the plasmid 
genotype (Figure S4.6; ANOVA, F3,56 = 76.92, p < 0.001; Post-hoc Tukey Tests, 
Evolved Host:Ancestral Host all p < 0.001). This suggests that chromosomal 
resistances reducing membrane permeability to antibiotics allowed evolved 
strains to start growing faster in the presence of TET.  
 
Whereas evolved bacteria grew equally well with evolved or ancestral plasmids, 
ancestral bacteria displayed impaired growth with evolved compared to 
ancestral plasmids (Figure S4.6; Max OD, W = 93, p < 0.01). This is consistent 
with the mutations in tetA/tetR reducing resistance but importantly confirms that 
this reduction is not evident when in combination with the chromosomal 
resistance mutations, which appear to compensate for the reduced efficacy of 
the plasmid-encoded efflux pump.  
 
We next competed evolved bacteria with either the evolved or ancestral plasmid 
against the ancestral MG1665(RK2) to compare the costs of carrying each 
plasmid genotype. The ancestral plasmid displayed a significantly higher cost 
than the evolved plasmid in the evolved chromosomal background (Figure S4.7, 
t25.71 = -2.287, p < 0.05). This suggests that the mutations to tetR/tetA ameliorate 
the cost of plasmid carriage but at the price of reduced efficacy of TET efflux. 
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This is consistent with previous studies showing a high cost of expressing the 
specific tetracycline efflux pump (Nguyen et al., 1989). Taken together with the 
growth data, this suggests that although mutations to tetA/tetR reduce growth 
under tetracycline in the ancestral chromosomal background, they have minimal 
effect on resistance in the evolved chromosomal background due to the reduced 
membrane permeability and additional efflux systems expressed in the evolved 
chromosomal background carrying mutations in ompF and acrR, leading to high 
resistance and a lowered cost of plasmid carriage. This suggests that the 
chromosomal resistance mutations must have been gained prior to the 
mutations in the plasmid-encoded tetracycline efflux pump. To test this, for one 
population (AT2) we tracked the frequency over time of an observed IS-insertion 
in ompF by PCR and then determined by sequencing when these genotypes 
acquired mutations in the tetA/tetR genes. Consistent with the hypothesised 
order of mutations, the IS-insertion in ompF was first detected at transfer 8 and 
had swept to fixation by transfer 32, whereas mutations in tetA/tetR were not 
observed in this ompF::IS background until transfer 32 (Figure S4.8). 
 
 
4.5 Discussion 
 
Our current model of bacterial evolution suggests that horizontal acquisition of 
ARGs accelerates resistance evolution by providing bacteria with ready-made 
resistance mechanisms, bypassing the requirement for rare de-novo mutations 
(Jain et al., 2003). However, recent population genomic data suggesting that 
lineages independently acquire and then subsequently coevolve with MDR 
plasmids (Johnson et al., 2016; McNally et al., 2016; Stoesser et al., 2016) imply 
a more dynamic evolutionary process. Consistent with this, here we show that 
gaining an ARG can be just the starting point in the evolution of resistance and, 
due to the costs of expressing horizontally acquired ARGs, does not preclude 
subsequent de novo evolution of chromosomal resistance. Evolved strains from 
TET-containing treatments gained chromosomal resistance mutations reducing 
membrane permeability and enhancing efflux of TET and providing cross-
resistance to other antibiotics, shortening lag phase in the presence of TET. 
These mutations also reduced the need for a fully operational plasmid-encoded 
tetracycline efflux pump, expression of which is highly costly (Nguyen et al., 
1989), allowing plasmid mutations in the TET efflux pump and its regulator 
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which reduced the cost of plasmid-encoded resistance. A consequence of this 
intragenomic coevolution is that the increased TET resistance of evolved strains 
from T, AT and A/T treatments required the action of both the chromosomal- 
and plasmid-encoded resistances, which together acted multiplicatively. Thus 
intragenomic coevolution can lead to the evolution of bacterial genomes 
comprised of co-dependent replicons, limiting the potential for onward 
transmission of the plasmid due to the weaker resistance it now encodes in 
other lineages.  
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5. High repeatability of bacteria-plasmid coevolution under 
antibiotic selection 
 
 
5.1 Abstract 
 
Plasmids are important agents of horizontal gene transfer that accelerate 
bacterial evolution by transferring ecologically important traits between cells and 
species. However, gaining and expressing horizontally acquired genes can be 
costly leading to intragenomic conflict between the chromosome and the 
plasmid. These evolutionary conflicts can be resolved by compensatory 
evolution – of the host, the plasmid, or reciprocal coevolution of both – to reduce 
the cost. The dynamics of bacteria-plasmid coevolution remain largely unknown. 
Here we show, through temporal sequencing of multiple populations of 
Escherichia coli carrying the multidrug resistance RK2 plasmid, highly 
repeatable plasmid-host coevolutionary dynamics under antibiotic selection. 
Across all independently evolving populations the order in which beneficial 
mutations arose was identical despite clonal interference between multiple 
competing lineages within the same populations. Carrying the plasmid combined 
with tetracycline selection in all cases favoured chromosomal resistance 
mutations, reducing the length of the lag phase of the cells, followed by 
mutations to the plasmid, impairing the tetracycline resistance. Finally, additional 
resistance associated chromosomal mutations were acquired. Together these 
mutations provided increased resistance combined with improved growth in the 
presence of tetracycline. Our study provides evidence that reciprocal 
coevolution between bacteria and plasmids can be remarkably repeatable. 
 
 
5.2 Introduction 
 
The horizontal gene transfer (HGT) of genetic material between lineages is an 
important driver of bacterial evolution, facilitating the rapid adaptation and 
diversification of prokaryotes (Ochman et al., 2000; Wiedenbeck and Cohan, 
2011). The acquisition of mobile genetic elements (MGEs) harbouring 
ecologically important accessory traits – as well as the genes required for their 
own replication, maintenance and horizontal transfer – promotes the innovation 
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of bacterial genomes, allowing bacteria to exploit novel niches (Nogueira et al., 
2009; Ramírez-Díaz et al., 2011) or become better adapted to their current 
niche (Schwarz and Johnson, 2016). A worrying example is the rapid spread of 
antibiotic resistance within pathogenic bacteria via the HGT of conjugative 
multidrug resistance (MDR) plasmids (Bennett, 2008; Carattoli, 2013). However, 
the introduction of novel MDR plasmids often leads to conflicts between the 
newly acquired genes and the pre-existing genetic background (Baltrus, 2013). 
Direct costs are imposed through the maintenance, translation and transcription 
of the plasmid-encoded genes (Park and Zhang, 2012). Whereas, indirect 
effects reduce fitness of the host through disruption of host cellular networks 
(Harrison et al., 2015; San Millan et al., 2015) and cytotoxic effects (Baltrus, 
2013). These costs can be ameliorated through compensatory evolution 
(Harrison and Brockhurst, 2012) dependent upon either the adaption of the 
plasmid (De Gelder et al., 2008) or host (Harrison et al., 2015; Loftie-Eaton et 
al., 2017; San Millan et al., 2014). Compensatory mutations can act directly to 
reduce the cost of the plasmid, affecting replication machinery or costly regions 
of the plasmid (Porse et al., 2016; Yano et al., 2016), or resolve disruption of 
cellular homeostasis; e.g., by limiting the bacteria’s SOS response or negating 
global transcriptional perturbations induced by the plasmid (Harrison et al., 
2015; Loftie-Eaton et al., 2017; San Millan et al., 2015; Sota et al., 2010). But 
there is growing experimental evidence that conflict between the plasmid and 
host can promote intragenomic coevolution between the independent replicons, 
thereby reducing the cost of the plasmid and increasing its persistence (Bottery 
et al., 2017; Loftie-Eaton et al., 2016). The order in which mutations are 
acquired by the chromosome and plasmid is likely to be important in the 
integration of plasmid in novel hosts. However, very little is known about the 
dynamics of bacteria-plasmid coevolution, or how repeatable this coevolutionary 
process is.  
 
In a recent study, we investigated the compensatory adaptation between 
Escherichia coli MG1655 and the multidrug resistant plasmid RK2 (conferring 
resistance to ampicillin and tetracycline) when under antibiotic treatment 
(Bottery et al., 2017). The newly acquired plasmid produced a considerable cost 
in the presence of tetracycline, however, over 530 generations of coexistence, 
the cost of RK2 carriage was ameliorated through intragenomic coevolution. A 
set of beneficial mutations on the chromosome, which increased resistance and 
growth in the presence of tetracycline, paved the way for a reduction in the 
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efficiency and cost of the plasmid bourn resistance. This lead to co-dependency 
between the two replicons, which now provided increased resistance at a 
decreased cost.  
 
In this study, we analyse four of the independently evolving populations from the 
previously published evolution experiment to investigate the repeatability of the 
coevolutionary dynamics within and between populations under tetracycline 
treatment. Through whole genome sequencing of clones across 530 
generations of coevolution from four independent populations, we examine the 
temporal dynamics of the gaining of beneficial mutations. We find that 
coevolutionary dynamics are remarkable repeatable between independently 
evolving populations. Interestingly, although there is evidence of co-occurring 
independent lineages with genetically different but functionally similar mutations 
within populations, the order of the acquisition of beneficial mutations is identical 
between independent lineages. Plasmid carriage combined with tetracycline 
treatment firstly lead to the acquisition of chromosomal mutations that increased 
resistance to tetracycline and also decreased the cells lag phase in the 
presence of tetracycline. These mutations were followed by mutations on the 
plasmid that have previously been shown to both decrease resistance and cost 
of the plasmid (Bottery et al., 2017). Finally, fine-tuning of resistance followed 
through the acquisition of secondary and tertiary chromosomal mutations. The 
data shows that the trajectory of intragenomic coevolution can be highly 
repeatable between independent lineages. 
 
 
5.3 Methods 
 
5.3.1 Experimental Design 
The evolution experiment, described previously (Bottery et al., 2017), coevolved 
Escherichia coli MG1655 with the multidrug resistance plasmid RK2 in various 
antibiotic treatments, to which the RK2 plasmid provided resistance. Cultures 
were grown at 37°C in 50 ml microcosms containing 5 ml of Oxoid® Nutrient 
Broth (NB) shaken at 180 rpm. Six independent biological replicates 
(populations) were initiated for each treatment, consistent with previous 
evolution experiments and sufficient to detect treatment specific parallel 
evolution (Harrison et al., 2015). Constant tetracycline treatments were 
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supplemented with 10 µg ml-1 tetracycline (populations T1-6) or 100 µg ml-1 
ampicillin plus 10 µg ml-1 tetracycline (populations AT1-6). The populations were 
evolved for ~530 generations (80 days), through daily transfers of 50 µl of 
saturated culture into 5 ml of fresh media supplemented with antibiotics specific 
to the treatment, yielding roughly 6.6 generations per day. OD600 of populations 
were measured daily. 500 µl samples from each population were frozen at -80°C 
on day zero and every 8 days (~53 generations) thereafter in 25% glycerol. 
Whole populations were also diluted and spread onto nutrient agar every 8 
days, with 20 individual colonies selected at random and frozen at -80°C. A 
single clone from day 80 (generation 530) the end of the experiment from each 
population was randomly selected for sequencing, along with 3 clones from 
transfers 8, 16 and 40 in populations T3, AT2 and AT5, and transfers 16, 24, 
and 48 in population AT3. Populations under constant tetracycline treatment 
were selected for further analysis based on the clones’ final sequenced 
genotype, so that the population contained insertion sequence (IS) elements 
within ompF and did not exhibit a hypermutator phenotype (no mutations within 
mutL of mutS). The time points chosen for sequencing were selected to provide 
samples prior to the observation of IS elements within the population based on 
whole population PCR, as well as the time point at which they were first 
observed and 24 transfers after first observing IS elements within the 
population.  
 
5.3.2 PCR tracking of mutations 
The frequency of IS mutation of the ompF genes was tracked within populations 
T4, AT2, AT3 and AT5 though whole population PCR. PCR primers amplifying 
ompF (Fw: ACTTCAGACCAGTAGCCCAC, Rv: 
GCGCAATATTCTGGCAGTGA) identified IS elements; a PCR short product of 
716 bp indicated no insertion sequence, a product of 1484 bp indicted IS1 and a 
long product of 1911 bp indicted IS5 within ompF. 5 µl of frozen whole 
populations from every 8 transfers was mixed with 10 µl of nuclease free water, 
1 µl of which was used as template for the PCR, resulting in approximately 1 × 
105 cells per PCR reaction. IS elements were never observed within the control 
population which coevolved with the RK2 plasmid in the absence of antibiotic 
treatment (N1). Twenty individual clones isolated from transfers 8, 16, 24, 32 
and 40 from populations T4, AT2, AT3 and AT5 were subsequently checked for 
the presence of IS elements within ompF using the above primers. Standard 
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PCR reactions were performed using Go Taq Green Master Mix (Promega) 0.4 
µM of each primer, on a program of 95°C for 5 min, 30 cycles of 95°C for 30 s, 
60°C for 30 s, and 72°C for 2min, with a final extension of 72°C for 5 mins. 
 
5.3.3 Sequencing and analysis 
Three clones without IS elements in ompF were randomly selected from transfer 
8 from populations T4, AT2, AT5 for sequencing, along with three clones from 
transfer 16, population AT3. Three random clones containing IS elements within 
ompF from populations T4, AT2, AT5, transfers 16 and 40, and three from 
population AT3 transfers 24 and 48 were also selected for sequencing. Each 
clone was grown for 24 hours until saturation in the same selective environment 
as they evolved in, before total genomic extraction using the DNeasy Blood and 
Tissue extraction kit (Qiagen) according to the manufactures instructions. The 
integrity of the DNA was assessed on a 0.75% agarose gel, and concentration 
estimated by Qubit dsDNA BR Assay Kit (Thermo Fisher Scientific). Total 
genomic DNA was sequenced by MicrobesNG (http://www.microbesng.uk), 
which is supported by the BBSRC (grant number BB/L024209/1), using 2 × 250 
base pair paired-end reads on the Illumnia MiSeq platform. Sequence adapters 
were trimmed using Trimmomatic (Bolger et al., 2014) and quality assessed 
using Samtools (Li et al., 2009), BedTools (Quinlan and Hall, 2010) and bwa-
mem (Li and Durbin, 2009) by MicrobesNG. Trimmed reads were mapped to the 
E. coli MG1655 K-12 and RK2 plasmid genomes available on NCBI, accession 
numbers U00096.3 and BN000925.1, respectively, using the Burrows-Wheeler 
short read aligner (Li and Durbin, 2009). Variants were called using GATK’s 
Unified Genotyper (McKenna et al., 2010) and annotated using SnpEff 
(Cingolani et al., 2012). Variants were filtered on base quality, coverage and 
single nucleotide polymorphisms (SNPs) around gaps. Insertion sequences 
were detected based on an over representation of larger inner mate gaps 
between mapped paired reads and structural variants were detected using 
Breakdancer (Chen et al., 2009). All variants were confirmed using the 
Integrated Genome Viewer (Robinson et al., 2011). To produce a set on 
mutations accumulated throughout the evolution experiment, variants that were 
also present in the previously sequenced ancestral strain (Bottery et al., 2017) 
were excluded. 
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5.3.4 Phylogenetic analysis  
The phylogenetic trees were produced based on the binary presence and 
absence of all observed mutations within the data set for each sequenced clone. 
This gives each observed mutation equal weight when building the trees, which 
is appropriate when variants are under strong selection (Tenaillon et al., 2016). 
Trees were built using the neighbour joining method provided by the R package 
ape {ape 4.0} (Paradis et al., 2004) and were rooted to no observed variants, i.e. 
the ancestral strain harbouring RK2. The strong parallelism of mutations 
between populations resulted in clones from different populations clustering 
within the same clades when a composite tree was produced. However, as the 
populations evolved independently, separate trees were produced for each 
population and combined into a single plot.  
 
5.3.5 Minimum inhibitory concentrations 
To measure the minimum inhibitory concentration (MIC) of tetracycline, clones 
were grown over night in 5 ml of NB. The saturated cultures were sub-cultured 
50 µl into 5 ml of fresh NB and allowed to grow until an OD600 of 0.5. These sub-
cultures were then diluted 1:400, to an initial density of ~5×105 CFU/ml, in 96-
well plates containing a log2 dilution series of tetracycline. Cultures were grown 
for 24 hours at 37°C, shaken at 600 rpm, 3 mm orbital radius, with OD600 
measured at the end point. Three technical replicates were conducted per clone. 
 
5.3.6 Growth Curves 
Growth curves were conducted using a Tecan infinite M200 Pro plate reader in 
96 well plates. Overnight cultures of clones were sub-cultured to an OD600 of 0.5 
in fresh NB, and then diluted 1:1000 into 100 µl NB supplemented with 10 µg ml-
1 TET. Cultures were grown at 37°C with shaking at 300 rpm, 3 mm orbital 
radius for 24 hours, and OD600 was measured every 16 minutes. Three technical 
replicates were conducted per clone. Growth rates were calculated as the 
maximum slope of log2 transformed OD600 covering four time points (~1 hour of 
growth), lag phase was calculated to end when growth rate reached 10% of the 
maximum achieved growth rate. 
 
5.3.7 Statistics 
Statistical analyses were performed in R (version 3.3.3). Linear and non-linear 
models were fit to the number of mutations acquired through time using Non-
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linear least squares fit, quality of fit was calculated using Akaike information 
criterion (AIC). Comparisons among MIC curves were calculated through 
comparing the area under the curve, and statistical differences in length of lag 
phase among clones were calculated using ANOVA, with subsequent Tukey 
multiple comparison of means. 
 
 
5.4 Results 
 
Populations of Escherichia coli were previously co-evolved with the MDR 
plasmid RK2 under either single, combined or cycling treatment with ampicillin 
or tetracycline for ~530 generations (Bottery et al., 2017). Under the 
tetracycline-containing treatments the chromosomal and plasmid replicons co-
evolved to become co-dependent, reliant upon each other to provide adequate 
resistance to the tetracycline concentration. Here, we explore the temporal 
coevolutionary dynamics of populations exposed to tetracycline treatments. 
Guided by previous whole genome sequencing of clones from the end-point of 
the selection experiment, the non-hypermutable populations T4, AT2, AT3 and 
AT4, which were evolved under constant tetracycline treatment (with [AT] or 
without [T] ampicillin), were selected for further analysis. Each population 
contained insertion sequence (IS) elements within ompF; loss of function of 
ompF was beneficial under tetracycline treatment (Bottery et al., 2017). To 
identify when these beneficial mutations of ompF occurred within the selected 
populations, whole population PCR of ompF was conducted (Figure S5.1), along 
with PCR of 20 individual clones from each population at transfers 8, 16, 24, 32 
and 40 (Figure S5.2). IS elements were first observed at transfer 16 in 
population T4, transfer 8 in populations AT2 and AT5, and transfer 24 in 
population AT3. 
 
5.4.1 Acquisition of mutations 
Clones were sequenced from time-points before and after the acquisition of IS 
elements within ompF to determine the variability in genotype both within and 
between populations. Three clones were randomly selected from the sampled 
transfer before the occurrence of IS elements within the population (transfer 8 
for populations T4, AT2 and AT5, transfer 16 for AT3), and then 8 and 32 
transfers after this point. A single end point clone (transfer 80) from each 
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population that had been previously sequenced (Bottery et al., 2017) was also 
analysed. In total we observed 143 mutations (Figure S5.3), comprising of: 71 
point mutations, 53 IS elements, 14 deletions and 5 duplications. Of these 
mutations 27 were intergenic variants and 3 were synonymous substitutions. 
The trajectories of the acquisition of mutations were similar across all 
populations, with the number of mutations increasing linearly over time (Figure 
5.1A/B, GLM, F1,28=181.98, P<0.01). Across all clones sequenced thirty-nine 
unique loci were affected by mutations, seven of which were parallel across the 
four populations. 
 
 
  
      
 
Figure 5.1 | A Average number of mutations through time, generation 530 has 1 
sequenced genome, other points show mean number of mutations observed 
within 3 independent clones isolated from same population, with bars 
representing SEM. B Points show number of mutations in each sequenced 
clone, pluses show grand mean of total observed mutations across all 
treatments. The solid line shows the best fit to 𝑚 = 𝑎𝑡, where 𝑎 = 0.0181, R2 = 
0.931. The dashed line shows the fit to 𝑚 = 𝑏 𝑡, ΔAIC = -21.24, R2 = 0.926. The 
dotted line shows the fit to the two parameter model, 𝑚 = 𝑎𝑡 + 𝑏 𝑡, ΔAIC = -
0.13, R2 = 0.932, models proposed by Tenaillon et al. (2016). Fits to individual 
populations are shown in Figure S5.4. 
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5.4.2 Population phylogenies 
Construction of phylogenies based on the presence or absence of mutations 
shows that there is considerable within population diversity across all four 
populations (Figure 5.2). The accumulation of short branches at the base of the 
trees shows early divergence, which was subsequent lost within the populations. 
As many of these mutations were not observed later in time, it is expected that 
these mutation were removed from the population through selective sweeps for 
more beneficial mutations.  
 
The subsequent population trajectories differ between populations. A single 
lineage appears to dominate population T4, diverging early within the 
experiment. Likewise, in population AT2 a single lineage dominated by transfer 
16, but was superseded by a second lineage that appears to have diverged 
earlier in time. In both of these populations the final sequenced clone came to 
dominate the population by half way through the experiment, suggestive of the 
stepwise acquisition of beneficial mutations and subsequent selective sweeps. 
Whereas, in populations AT3 and AT5, the phylogeny has deeper branching, 
showing that lineages coexisted despite strong selection for beneficial 
mutations. Thus, multiple different mutations with potentially similar fitness gains 
were emerging in parallel and being maintained within a single population. 
Despite identical selection conditions between the AT treatments, and parallel 
evolution observed to the gene loci level after 530 generations, the population 
dynamics leading to these parallel mutations differed between independently 
evolving lines. Whereas some populations were dominated by a single lineage, 
others had coexisted lineages over long periods of time. 
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Figure 5.2 | Phylogeny of sequenced clones isolated from population T4, AT2, 
AT3 and AT5 rooted the ancestral MG1655(RK2). Distance matrix was 
constructed from the binary presence of absence of mutations, specific to the 
nucleotide level, relative to the ancestral strain. The scale bar represents 
number of mutations. Branch node labels and colour of branches show the 
transfer from which the clones were isolated.  
 
 
5.4.3 Parallel evolution 
Selection of MG1655(RK2) under constant tetracycline treatment led to mutated 
loci that were strikingly parallel across independent replicate populations, and 
therefore indicative of beneficial mutations under positive selection at these sites 
(Bottery et al., 2017). Across all four populations sequenced, the order of the 
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mutation gained by all four populations was the lost of function of ompF via the 
acquisition of an IS element at transfers 16 or 24 (Figure 5.3). OmpF is a 
membrane protein that allows the passive diffusion of small molecules, including 
tetracycline, across the cell membrane (Phan and Ferenci, 2017). There is some 
genetic variability observed prior to the acquisition of ompF mutations, but these 
mutations are mostly lost from the populations upon the loss of function of 
ompF. Clones isolated from transfer 16, that had IS elements within ompF, had 
significantly increased resistance to tetracycline when compared to clones 
isolated from transfer 8 or the ancestral strain (Figure 5.4, Post-hoc Tukey 
Tests: Anc(RK2):Transfer 16 all p > 0.05, see Table S5.1 for ANOVA tables). By 
transfer 16 all clones also had a significantly reduced lag phase compared to the 
ancestral strain (Figure S5.8, Post-hoc Tukey Tests: Anc(RK2):Transfer 16 all p 
> 0.05, See Table S5.2 for ANOVA tables). IS elements were observed within all 
subsequent time points, but only in population T4 was the same IS element 
observed consistently throughout the experiment. Clones isolated from 
population AT2 at transfer 16 had IS5 within ompF and a SNP in gfcD (encoded 
within an inactive operon in MG1655-K12 (Peleg et al., 2005)), which were lost 
from the population, displaced by a lineage which inactivated ompF through the 
insertion of IS1. Populations AT3 and AT5 had one of three different IS 
elements; IS1, IS2 and IS5 within ompF. These results suggest that the 
beneficial loss of function of ompF evolved independently multiple times within a 
single population (Figure 5.3). However, the variation in MIC among clones from 
these populations at any one time point was low (Figure S5.5-5.7), showing that 
independent lineages with the same functional mutations had similar resistance 
profiles. 
 
Across all populations the next beneficial mutations to occur were SNPs within 
the plasmid bourn tetA or tetR genes, encoding a tetracycline specific efflux 
pump and its negative regulator, respectively (Schnappinger and Hillen, 1996). 
These mutations reduced the level of resistance to tetracycline when present in 
a wild-type background, but also reduced the cost of the plasmid (Bottery et al., 
2017). This order of mutations is consistent with the hypothesis that mutations 
within tetA and tetR are reliant upon the prior acquisition of ompF mutations. 
Interestingly, there was no significant difference in the MIC between clones from 
transfer 16 and 40 (Post-hoc Tukey Tests: Transfer 16:Transfer 40 p > 0.05), 
suggesting that ompF mutations alone mask the decreased efficacy of the 
mutated plasmid-encoded efflux pump. 
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Figure 5.3 | Each panel shows the mutations observed within each population 
during constant selection under tetracycline treatment. Concentric rings 
represent E. coli chromosomes or RK2 plasmids, ring colour represent the time 
point the clones were isolated (see keys); inner lighter rings to outer darker rings 
represent the progression through time. Sets of three concentric rings are 
represent three independent clones isolated from the same time point within that 
population. Points on the plot represent mutations at specific loci, circles = non-
synonymous mutations, bars = frame shift inducing deletions, squares = 
duplications, and triangles = IS elements (colours show type of IS element, see 
key). 
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Figure 5.4 | The change in tetracycline resistance profile through time in 
population A T4, B AT2, and C AT5. The vertical line represents the 
concentration of tetracycline selected for during the evolution experiment. Points 
represent the collective mean of the three sequenced independent clones from 
each time point with error bars showing SEM. For individual MIC curves for each 
clone see Figure S5.5-5.7. 
 
 
Transfer 40 is the first time point that we see the loss of function of ychH, a 
hypothetical gene encoding a general stress response (Lee et al., 2010), 
potentially not required under tetracycline selection. Loss of function was either 
through acquisition of IS elements or mutations generating frameshifts early 
within the gene, with both methods of inactivation present within populations 
AT3 and AT5. The final mutation to occur across all populations was within 
acrR, which negatively regulates the acrAB genes (Su et al., 2007), being only 
observed within clones isolated from the end of the evolution experiment 
(transfer 80). The loss of function of acrR is associated with the overexpression 
of AcrAB-TolC multidrug efflux pump, leading to MDR phenotypes (Okusu et al., 
1996; Wang et al., 2001) and increased growth in the presence of tetracycline 
(Bottery et al., 2017). Genetically different mutations within tetA, ychH and acrR 
occurred within multiple independent lineages containing different IS elements 
within ompF (Figure 5.3). The acquisition of these secondary mutations within 
ychH and acrR in populations T4 and AT5 did not significantly increase the 
resistance to tetracycline (Figure 5.4, Post-hoc Tukey Tests, populations T4, 
AT5: 16:40:80 all p > 0.05). Interestingly, population AT2 did not acquire 
mutations within either ychH or acrR and unlike populations T4 and AT5, the 
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MIC decreased in clones isolated from population AT2 at transfer 80, reduced 
back down to a level which was not significantly different from the ancestral 
strain (Figure 5.4, Anc-RK2:AT2-80 p = 0.481). Potentially, the acquisition of 
subsequent parallel mutations is required to maintain high levels of resistance 
observed within populations T4 and AT5. End-point clones from populations T4 
and AT5, also showed increased growth rates when compared to the ancestral 
strains (although these gains were not significant, Figure S5.8), whereas, end-
point clones from population AT2 did not show this effect, potentially due to the 
lack of mutation of acrR and ychH. Thus, the early chromosomal mutations had 
the large benefit of allowing cells to grow significantly faster in the presence of 
tetracycline, while subsequent mutations had smaller effects on growth that are 
difficult to distinguish through analysis of growth curves alone.  
 
The order of beneficial mutations was consistent across all four populations, 
with mutations of ompF followed by tetA/R, then ychH and finally acrR (Figure 
5.3). The only parallel mutations not to show temporal consistency between 
populations was a highly parallel SNP within adhE, encoding an alcohol 
dehydrogenase which is involved in multiple metabolic pathways (Kessler et al., 
1991) and known to exhibit binding activity to the 30S ribosome under aerobic 
respiration (Shasmal et al., 2016), the primary target of tetracycline. These 
mutations fluctuate in frequency both within and between populations, being 
observed only early on in population AT3, consistently in all transfers in 
population AT5 and only in the later half of the experiment in populations T4 and 
AT2. 
 
 
5.5 Discussion 
 
Our results demonstrate that plasmids not only act as facilitators of HGT, but 
due to evolutionary conflict with the host chromosome, also selects for 
intragenomic coevolution. The acquisition of the RK2 MDR plasmid provides the 
benefit of resistance in the short term despite costs associated with carriage of 
the plasmid. However, over longer periods of antibiotic selection with 
tetracycline, a highly parallel set of mutations occurs both on the plasmid and 
host’s chromosome, reducing the plasmids cost (Bottery et al., 2017). Here we 
show that the observed coevolution between plasmid and host follows the same 
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order of mutations between independently evolving populations. This was 
despite the coexistence of independently competing lineages within some of the 
populations. We found that across all lineages, mutations within a 
chromosomally encoded outer membrane pore were followed by the mutation of 
the plasmid encoded tetracycline resistance genes. Subsequent mutation of 
chromosomal stress response and multidrug efflux systems followed. Their 
phenotypic effects upon resistance and growth of the bacteria potentially govern 
the common order of mutations. 
 
The expression of the RK2 encoded tetracycline specific efflux pump is costly 
(Modi et al., 1991; Nguyen et al., 1989); mutations in the pump were able to 
reduce both the cost and efficiency of the pump (Bottery et al., 2017). But, in the 
presence of tetracycline, these mutations reduce the growth of the ancestral 
bacteria, as there are no additional resistance mechanisms to compensate for 
the reduction in efflux efficacy. Therefore the reduction in resistance caused by 
the plasmid mutations was hypothesised to rely upon the prior acquisition of 
additional chromosomal resistance mutations. Supporting this hypothesis, the 
mutational loss of function of ompF always occurred first across all of the 
sequenced populations. This mutation was likely selected for due to the 
significantly decreased length of the lag phase it conferred to cells in the 
presence of tetracycline. But, importantly the mutational loss of function of ompF 
also increased the level of resistance to tetracycline, providing a buffer to allow 
the mutational reduction in plasmid bourn resistance to sweep into the 
population. Following the early acquisition of ompF and tetA/R mutations, 
secondary resistance associated mutations in ychH and then acrR arose within 
the populations. Again the order of these mutations was highly parallel both 
within and between populations. End-point clones that had gained these 
mutations maintained high levels of resistance and showed an increase in 
growth rate, whereas a population that never acquired mutations within ychH 
and acrR did not, suggesting the potential importance of continual innovation 
when under tetracycline selection.  
 
Here we measured the phenotypic effects the incremental acquisition of 
mutations, these help to explain the parallelism of the order of mutations 
between lineages. However, the highly repeatable order of mutations may also, 
in part, be due to diminishing returns epistasis (Chou et al., 2011), where by the 
extent of the benefit provided by mutations governs when they are selected 
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within a population. It would be expected that mutations with larger fitness 
effects will be selected early, with less beneficial mutations appearing in the 
population later. This pattern is implicit in the phenotypic data, with the early 
mutation of ompF having the largest phenotypic effect. However, in order to 
elucidate the direct fitness benefits of the incremental mutations descripted 
here, the direct competition between evolved lineages is required. 
 
There is a growing body of evidence that the gaining of a plasmid can promote 
reciprocal coevolution of both plasmid and bacteria, reducing the cost imposed 
by the plasmid and helping to stabilise their existence within lineages (Bottery et 
al., 2017; Loftie-Eaton et al., 2016). The footprints of coevolution between host 
and plasmid are also present in bacterial genomes, with the rapid expansion 
and diversification of E. coli sequence types following the acquisition of MGEs 
by multiple independent lineages (McNally et al., 2016; von Mentzer et al., 
2014). Our data suggests that this coevolution between plasmid and host can be 
highly structured, following a specific path governed by the phenotypic effects of 
mutations upon the resistance and growth of the bacteria. Further work will have 
to be conducted to determine if the dynamics of other examples of reciprocal 
coevolution between plasmid and host are similarly highly repeatable.
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6. Discussion 
 
Plasmids play a fundamental role in the evolution of antimicrobial resistance 
(AMR). The ability of plasmids to transmit between often distantly related 
bacterial lineages and accumulate multiple resistance genes means that they 
pose one of the greatest challenges in dealing with the emergence of AMR. Yet, 
our understanding of the selection and evolution of multidrug resistance (MDR) 
plasmids is limited. The data presented in this thesis demonstrates that the 
dynamics of both selection and evolution of MDR plasmids can vary dependent 
upon the plasmid encoded antimicrobial genes (ARGs) under selection. I show 
that the sociality of the contrasting antibiotic resistance mechanisms encoded by 
a MDR plasmid determined the selective conditions for the plasmid (Chapter 2). 
Furthermore, the mechanistic details of antibiotic resistance, along with mode of 
action of the antibiotic, were shown to be essential to produce mathematical 
models that accurately predict selection for resistance (Chapter 3). These two 
chapters address how short-term antibiotic selection can overcome the costs of 
plasmid carriage, but in the longer-term, compensatory evolution can stabilise 
MDR plasmids within bacterial populations by reducing the costs associated 
with plasmid carriage. I went on to examine how the mode of compensatory 
evolution varies with antibiotic treatment. I found that tetracycline treatment, but 
not ampicillin treatment led to intragenomic coevolution between the RK2 
plasmid and it’s host Escherichia coli. Coevolution ameliorated the cost of 
plasmid borne tetracycline resistance, but also created a co-dependency 
between the plasmid and its host (Chapter 4). The coevolutionary dynamics 
between E. coli and RK2 were strikingly repeatable across the independently 
evolving populations despite the emergence of multiple competing lineages 
within populations (Chapter 5). The data presented in the thesis demonstrates 
that a combination of positive selection and compensatory evolution can help to 
explain why MDR plasmids persist within bacterial populations despite their 
inherent fitness cost. 
 
 
6.1 Selection for Multidrug Resistance Plasmids 
 
The thesis highlights the importance of plasmid cost in the selection and 
maintenance of MDR plasmids. Although the underlying molecular bases of 
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plasmid costs are poorly understood (Millan and MacLean, 2017), the fitness 
burden imposed by plasmids is a fundamental driver of plasmid and host 
evolution (Harrison et al., 2015; Loftie-Eaton et al., 2017; San Millan et al., 
2015). The cost of plasmid carriage generates purifying selection against 
plasmid-carrying strains, the thesis first explores how positive selection for 
plasmid-encoded traits can overcome this purifying selection. Recent studies 
have shown that it can take only a very small concentration of antibiotic, far 
below the minimum inhibitory concentration (MIC) of sensitive plasmid-free 
strain, to select for costly plasmids (Andersson and Hughes, 2014; Gullberg et 
al., 2014). However, MDR plasmids can encode qualitatively different 
mechanisms of resistance, ranging from cooperative to selfish. In Chapter 2 I 
show that the sociality of resistance can alter the selective conditions for a MDR 
plasmid. Plasmid encoded cooperative inactivation of ampicillin was selected for 
at concentrations of antibiotic higher than the MIC of the plasmid-free strain. The 
enzymatic inactivation of ampicillin by resistant cells permitted a sensitive sub-
population to survive past their MIC by reducing the environmental ampicillin 
concentration. In contrast, selection for a tetracycline efflux pump, encoded on 
the same MDR plasmid, occurred at just 1/100th of the MIC of the sensitive 
plasmid-free strain. Furthermore, selection for a cooperative resistance 
mechanism, but not a selfish resistance mechanism, was negatively frequency 
dependent, resulting in a higher fitness of plasmid containing strain when they 
were rare. Mass action modelling helped confirm that the inactivation of 
antibiotic did provide a shared benefit of resistance, but importantly showed that 
the inclusion of both mode of action and mechanism of resistance are required 
to accurately predict the selection for resistance. Interestingly, the inactivation of 
bacteriostatic antibiotics permitted cooperation across a wider range of 
parameters than the inactivation of bactericidal antibiotics. 
 
The levels of antibiotic contaminating natural environments can vary across 
orders of magnitude, ranging from very high concentrations – mg ml-1 in 
industrial sewage (Larsson et al., 2007) – to very low concentrations – ng or pg 
ml-1 in soil and water (Kümmerer, 2009; Zhang and Li, 2011). Our results show 
that even at these very low sub-MIC concentrations of antibiotic, selfish 
resistances such as efflux pumps will be selected for, driving the competitive 
exclusion of sensitive cells. Selfish resistances therefore seem to be especially 
important for the selection of MDR plasmids in environments with very low 
concentrations of antibiotic.  
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Multiple different antibiotics are often present at low levels within a single 
environment (Kim et al., 2011; Valcárcel et al., 2011). This is of concern due to 
the combined effects of multiple antibiotics demonstrated by the results 
presented in chapter 2 and 3. Combining two antibiotics at very low 
concentrations, each of which individually was insufficient to select for the 
resistance plasmid, together selected for the plasmid when in combination. 
Environmental pollution with multiple antibiotics may therefore be a contributing 
factor for the persistence of environmental MDR plasmids, even when each 
antibiotic is present at concentrations below the level required to select for 
resistance. 
 
Coexistence of sensitive and resistant bacteria can occur when the benefit of 
resistance is shared in well-mixed populations, via the inactivation of the 
antibiotic. However, bacteria often live within complex spatially structured 
communities such as biofilms (Nadell et al., 2016). Limited diffusion and local 
interactions mediated by structured environments, such as biofilms, could vastly 
change population level effects of resistance by disproportionally directing the 
benefits of social resistances to the resistant sub-population. Spatial segregation 
and reduced diffusion within biofilms has been observed to promote cooperative 
behaviours in bacteria, such as the production and secretion of iron scavenging 
siderophores where the public good is preferentially utilised by neighbouring co-
operators (Kümmerli et al., 2009). Whether biofilms promote or suppress 
cooperative antibiotic resistance is unknown. However, the modelling results 
presented in chapter 3 suggest that the survival of a sensitive sub-population 
may be more likely when in co-culture with a resistant population that inactivates 
bacteriostatic antibiotics as an initially high concentration of bacteriostatic does 
not kill sensitive cells. This may be of particular importance within structured 
populations where the public good of reduced antibiotic concentration is not 
immediately available to the sensitive sub-population. In support of this 
hypothesis, one of the few studies that has examined cooperative antibiotic 
resistance within spatially structured environments showed that the inactivation 
of chloramphenicol (a bacteriostatic antibiotic) allowed the survival of sensitive 
cells both on agar plates and within in vivo mouse models (Sorg et al., 2016). 
 
Understanding how antibiotic resistance is selected for is a central goal of 
studying the spread of MDR plasmids. There are many forms of both selfish (Li 
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et al., 2015) and cooperative (Wright, 2005) resistances that can be encoded 
upon MDR plasmids. The social implications of these plasmid-encoded 
resistances are often overlooked; the thesis highlights the importance of 
quantifying the social interactions imparted by resistances in order to gain an 
understanding of the selection and maintenance of MDR plasmids within 
bacterial populations.  
 
 
6.2 Evolution of Plasmid Borne Resistance 
 
Antibiotic treatment can lead to the competitive exclusion of antibiotic sensitive 
cells from a population and positively select for MDR plasmids. However, 
positive selection alone does not resolve the intragenomic conflicts between 
plasmid and host; the underlying costs of plasmid carriage are still present even 
when the plasmid is acting as a mutualist (in the presence of positive selection). 
Studies have shown that compensatory evolution can act to ameliorate the cost 
of plasmid carriage when a plasmid is acting as a parasite (in the absence of 
positive selection) but also when it is in a mutualistic relationship with the 
bacterial host (Harrison et al., 2015). An outstanding question was how the 
mode of compensatory evolution following the acquisition of a MDR plasmid 
varies with antibiotic treatment.  We addressed this question through 
experimental evolution of E. coli carrying the MDR plasmid RK2 under a range 
of antibiotic treatments. We found that populations treated with tetracycline had 
an evolutionary trajectory distinct from populations that were not treated with 
tetracycline, which led to mutations both on the chromosome and plasmid. De 
novo chromosomal resistance mutations that arose under tetracycline treatment, 
despite pre-existing plasmid resistance, provided cross-resistance to other 
antibiotics and a shortened lag phase in the presence of tetracycline. These 
chromosomal mutations enabled the acquisition of mutations within the plasmid 
borne tetracycline efflux pump that reduced its level of resistance and cost. 
Further examination of populations evolving under constant tetracycline 
treatment revealed that the coevolutionary dynamics were highly repeatable. 
Despite clonal interference between multiple competing lineages within 
populations, the order of beneficial mutations was always the same. 
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A worrying consequence of the intragenomic coevolution observed under 
tetracycline treatment was that the coevolved plasmid and host together acted 
multiplicatively (Bottery et al. 2017), providing an increased level of resistance to 
tetracycline and cross-resistance to chloramphenicol at a reduced cost. 
However, neither the de novo chromosomal resistance mutations nor the 
evolved plasmid efflux pump provided a sufficient level of resistance for the E. 
coli to survive at the level of tetracycline it had been selected for. Thus, following 
intragenomic coevolution the two replicons became co-dependent, this 
potentially limited the ability of the plasmid to be transmitted and stability 
maintained in other lineages due to the weaker resistance it encoded. 
 
It is clear from our results that the evolutionary trajectory following the 
acquisition of a MDR plasmid does vary with antibiotic treatment.  An 
outstanding question arising from this result is what caused the differences in 
the evolutionary trajectories following treatment with ampicillin or tetracycline. 
Our results suggest the main cause of the differences in evolutionary trajectories 
were due to the costs of resistance. Although the bla gene encoding β-
lactamase on the RK2 plasmid is constitutively expressed (Wilson et al., 1997), 
the β-lactamase does not require any other substrates in order to catalyse the 
hydrolysis of ampicillin (Shaikh et al., 2015). Therefore, it is likely that this 
resistance mechanism is not particularly costly, as it does not consume cellular 
resources once the β-lactamase proteins have been produced. In contrast, 
although the expression of the TetA efflux pump is strongly negatively repressed 
by TetR in the absence of tetracycline, high levels of expression of tetA can be 
triggered with very little tetracycline (Nguyen et al., 1989). Once expressed, the 
efflux pump, unlike β-lactamase, is energy dependent – potentially limiting 
cellular resources (Levy, 2002) – but it also disrupts the cell physiology through 
the insertion into the membrane (Nguyen et al., 1989). This difference in the 
cost of expression between the two resistance mechanisms may have been the 
cause of two differing evolutionary trajectories, allowing the acquisition of 
immediate effect chromosomal mutations and modulation of the plasmid-borne 
resistance when under tetracycline selection.  
 
The mechanism of action of the two antibiotic resistances may have also 
contributed to the differences between the evolutionary trajectories adopted 
under ampicillin and tetracycline selection. The RK2 encoded β-lactamase is 
predicted to inactivate all ampicillin within the microcosm within just five hours of 
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growth (see chapter 3). This will have resulted in the bacteria to be under 
periodic ampicillin selection, with bacteria exposed to very little antibiotic for the 
majority of the experiment. In contrast, the efflux of tetracycline from the cell is a 
continual process required throughout the growth cycle of the cells. The more 
constant selection pressure imposed by tetracycline treatment and not ampicillin 
treatment may have also contributed to the difference in evolution observed 
between the two treatments.  
 
To gain a clearer picture of how antibiotic treatment alters evolution following the 
bacterial acquisition of a MDR plasmid a greater range of resistance plasmids 
must be examined. A future direction may be to examine the positive selection 
of plasmids harbouring potentially less costly resistance mechanisms which 
remain under constant selection, such as tetM, which acts to block the binding 
of tetracycline to the ribosome (Dönhöfer et al., 2012). An alternative is to 
explore the selection of a potentially more costly form of antibiotic inactivation 
such as group transfer – kanamycin phosphotransferase or chloramphenicol 
acetyltransferase for example – which requires energy in the form of ATP and 
acetyl-CoA respectively (Leslie, 1990; Wright and Thompson, 1999). 
 
The horizontal acquisition of ARGs encoded on MDR plasmids accelerates the 
evolution of antibiotic resistance by introducing new resistance genes into 
bacteria in a single step, by-passing the need for rare de novo resistance 
mutations (Bennett, 2008; Jain et al., 2003). However, bacterial genomes show 
the footprints of coevolution between horizontally acquired genetic elements and 
host chromosomes. The pathogenic E. coli lineage ST131 was observed to 
have multiple co-existing subtypes; chromosomal mutations within each were 
associated with the maintenance of different horizontally acquired genetic 
elements, including plasmids (McNally et al., 2016). The data presented in 
chapters 4 and 5, together with these recent findings, is suggestive of a more 
dynamic evolutionary process, whereby the acquisition of a conjugative MDR 
plasmid can act as a catalyst for the adaptation of both chromosomal and 
plasmid encoded genes.  
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6.3 Conclusions 
 
Antibiotic resistance in bacteria is a global threat to public health, and the 
horizontal transfer of MDR plasmids is a key vector for the acquisition and 
spread of antibiotic resistance in commensals and pathogens (Bennett, 2008). 
Although MDR plasmids benefit bacteria under antibiotic treatment, the carriage 
of plasmids can also impose a significant fitness cost upon novel bacterial hosts. 
Research into the maintenance of MDR plasmids has begun to identify the role 
of fitness costs, positive selection and compensatory evolution in explaining 
plasmid-host dynamics. My research demonstrates the interaction between 
these factors: both positive selection and compensatory evolution can help to 
explain the persistence of MDR plasmids in the clinic and environment. 
 
The results of the thesis paint a worrying picture, even when MDR plasmids are 
costly only a very small concentration of antibiotic is required to overcome this 
cost and select for resistance. When resistance is cooperative it may take a 
higher relative concentration to select for resistance; however, resistance will 
likely be maintained within bacterial populations exposed to sub-MIC levels of 
antibiotic through negative frequency dependent selection. Importantly, the point 
at which resistance will be selected for is dependent upon the cost of resistance. 
Therefore, cost free resistance mechanisms could be maintained within 
populations without any exposure to antibiotics. I have shown that it only takes a 
short period for compensatory mutations to arise and reduce the cost of an MDR 
plasmid. Moreover, positive selection for resistance can lead to not only a 
reduction in the cost of resistance, but also an increased level of resistance and 
cross-resistance. It is critical therefore that we reduce the levels of antibiotic 
exposure in the environment, and optimise current drug regimens to limit long-
term exposure to sub-MIC levels of antibiotics. Despite the advances presented 
here and elsewhere (Gullberg et al., 2014; Harrison et al., 2015; Loftie-Eaton et 
al., 2017; Porse et al., 2016; San Millan et al., 2015), our ability to predict the 
evolution of plasmid-mediated antibiotic resistance remains limited, particularly 
within clinically relevant settings. Future work needs to explore how the 
evolution of antibiotic resistance proceeds in clinically relevant pathogen-
plasmid combinations within more complex microbial environments.  
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Appendices 
 
Appendix A: Chapter 2 
 
 
 
Figure S2.1 | Growth curves of marked strains show no difference in growth 
dynamics between marked strains, with or without RK2 plasmid. Bacteria were 
grown in 96-well plates at 37°C with periodic shaking in a Tecan Infinite 200 Pro 
plate reader, with OD600 measured every 30 mins. Error bars represent SEM 
(n=6). 
 
 
 
Figure S2.2 | No significant difference in fitness of MG1655::gfp strain and 
MG1655::mcherry strain (t test t = 0.6001, df = 11, p-value = 0.5606) or between 
MG1655::gfp(RK2) and MG1655::mcherry(RK2) (two sample t test t = 0.5186, df 
= 16, p-value = 0.6944) when competed in antibiotic free media. Green bar 
represents RK2 plasmid in MG1655::gfp background competed against 
MG1655::mcherry and red bars are RK2 plasmid in MG1655::mcherry 
background competed against MG1655::gfp. Error bars represent SEM (n=6). 
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Figure S2.3 | Quantification of GFP and mcherry marked MG1655 strains in co-
culture using flow cytometry. A Density plots showing SSC vs DAPI signals, 
bacterial cells were differentiated from noise based on a positive DAPI signal as 
SSC alone does not accurately split the two. B Density plots showing SSC vs 
GFP signal, GFP expressing cells are easily distinguishable from mcherry 
expressing cells, ratios of the two strains were used to calculate selection rates. 
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Figure S2.4 | Plots of cell densities of plasmid free and RK2 plasmid containing 
populations in competition, these data were used to calculate the relative fitness 
of plasmid bearing strain (figure 2.3A/B in text). Note that relative fitness (W) 
relies on positive growth of both competing strains. Error bars represent SEM 
(n=6). 
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Figure S2.5 | High concentrations of tetracycline cause extinction of sensitive 
population when in competition. Green bars are the RK2 plasmid in 
MG1655::gfp background competed against MG1655::mcherry and red bars are 
the RK2 plasmid in MG1655::mcherry background competed against 
MG1655::gfp. Upward arrows represent a relative fitness above 2 i.e. no 
observable sensitive bacteria within the population. Error bars represent SEM 
(n=3). 
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Figure S2.6 | Log10 selection rates (r) of plasmid bearing E. coli vs plasmid free 
E.coli as a function initial plasmid frequency under (A,B) ampicillin selection and 
(C,D) tetracycline selection. Points show means of six independent replicates; 
with error bars showing SEM. B and D show the same data as panels plotted as 
heat maps.  
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Appendix B: Chapter 3 
 
 
    
    
Figure S3.1 | Fitting of simulated monocultures to empirical MIC data. The black 
line shows E. coli density after 24 hours growth at increasing concentrations of 
tetracycline or ampicillin, with error bars representing SEM (n=6). The blue lines 
show the population density at t=24 hr of the best parameter fit of numerical 
solution to models (1)-(3) when simulated in monoculture. A Plasmid free MIC in 
tetracycline, 2 µg ml-1, 𝐾𝑚𝑎𝑥!" = 1.25, 𝐾𝐴!"!" = 0.08 B Plasmid containing MIC 
in tetracycline, 64 µg ml-1, 𝐾𝑚𝑎𝑥!" = 1, 𝐾𝐴!"!" = 10.6 C Plasmid free MIC in 
ampicillin, 9 µg ml-1, 𝐾𝑚𝑎𝑥!" = 1.5, 𝐾𝐴!"!" = 4.5 D Plasmid containing MIC in 
ampicillin, >4096 µg ml-1, as the full curve was not available, 𝐾𝐴!"!" was 
selected to provide growth at 4096 µg ml-1 ampicillin, 𝐾𝑚𝑎𝑥!" = 1.5, 𝐾𝐴!"!" = 
3200. 
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Appendix C: Chapter 4 
 
 
Figure S4.1 | Persistence of plasmid at transfer 80, generation ~530. Bars show 
mean percentage of 20 evolved colonies from transfer 80 positive for RK2 
plasmid by PCR, 6 independent populations per treatment, error bars show 
SEM.  
 
 
Figure S4.2 | Number of mutations per genome. Bar charts show number of 
mutations per evolved clone in each treatment. The dark area of bar represent 
chromosomal mutations and the light area represent plasmid mutations. 
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Figure S4.3 | Mutations observed in each evolved independent population. 
Each ring represents the chromosome or RK2 from a single clone from each 
independent population, populations 1 to 6 from inner ring to outer ring. Dots (●) 
represent SNPS and sort indels, triangles (▲) represent insertion sequences, 
squares (◼) represent large duplications and bars (❙) represent large deletions. 
Mutations which are present within the same loci in two or more clones from the 
same treatment are labelled.  
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Figure S4.4 | Loss of function of OmpF multiplicatively increases tetracycline 
resistance when in combination with plasmid based efflux pump. Growth of keio 
knockout strains in the presence tetracycline in comparision to ancestral 
MG1655. Dashed lines represent ancestral strains, solid lines represent 
knockout strains, with light lines showing plasmid free growth and dark lines 
showing growth when harbouring RK2 a, E. coli K-12 ΔompF (JW0912) b, E. 
coli K-12 ΔychH (JW1196) c, E. coli K-12 ΔacrR (JW0453). Error bars represent 
SEM of six replicates.  
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Figure S4.5 | Relative fitness of evolved plasmid bearing populations. The 
relative fitness of evolved plasmid containing strains verses ancestral plasmid 
free strains when under no antibiotic selection. Bars represent mean of one 
randomly selected clone from each of the six replicate populations, error shows 
SEM. The black line represents the fitness of the ancestral plasmid carrying 
strains verses ancestral plasmid free, with the shaded grey area showing SEM 
(n=6). Evolved clones selected without antibiotics or with AMP increased in 
fitness (one-sample t test from 1 N: mean = 1.0047, s.e. = 0.019, t5 = 0.2445, p 
= 0.8166, A: mean = 1.0733, s.e. = 0.0109, t5 = 6.709, p < 0.05). Evolved clones 
constantly exposed to TET (T and AT treatments) remained significantly less fit 
than the ancestral plasmid free MG1655 in antibiotic-free media (one-sample t 
test from 1 T: mean = 0.9059, s.e. = 0.0224, t5 = -4.192, p < 0.05, AT: mean = 
0.8938, s.e. = 0.0.0321, t5 = -3.300, p < 0.05). 
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Figure S4.6 | Chromosomal resistances reduce lag time. Growth curves of: 
evolved host with evolved plasmid, evolved host with ancestral plasmid, 
ancestral host with evolved plasmid and ancestral host with ancestral plasmid, 
in TET 10µg/ml (the TET concentration used in the selection experiment), from 
either T, AT or A/T treatments. Mean of one randomly selected strain from each 
of the six replicate populations per treatment, error bars represent SEM.  
 
 
 
Figure S4.7 | Plasmid mutations ameliorate the cost of chromosomal 
resistances. The relative fitness of evolved strains from T treatment harbouring 
either their evolved plasmid or ancestral plasmid competed against ancestral 
MG1655 with ancestral RK2 plasmid, bars show the mean of 18 replicates, with 
error bars showing SEM. 
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Figure S4.8 | Plasmid tetA/tetR mutations only occur after acquiring insertion 
sequences in ompF. Bars represent the number of independent clones from 
population AT2 that have ompF::IS mutations, detected by PCR, and the 
number of clones within this background with tetA or tetR mutations, detected by 
Sanger sequencing.  
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Figure S5.1 | Whole population PCR of ompF within populations N1, T4, AT2, 
AT3 and AT5. Short bands of 716 bp indicate on aquisiiton of IS elements within 
ompF. Bands of 1484 bp show the acquisition of IS1, and bands of 1911 bp 
show the acquisition of IS5 within ompF. The insertion of IS elements was never 
ombserved within the control population evolving with RK2 under no antibiotic 
selection. Lanes marked with M contain size markers. 
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Figure S5.2 | Frequency of IS elements witin ompF between transfers 8 and 40 
in population T4, AT2, AT3 and AT5. Bars represent the number of independent 
clones from population AT2 that have ompF::IS mutations, detected by PCR.  
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Figure S5.3 | Number of mutations within each clone through time in 
populations T4, AT2, AT3 and AT5. Solid fill shows chromosomal mutilations, 
dashed fill shows plasmid mutations. 
 
Figure S5.4 | Fits of models to the acquisition of mutations within populations 
T4, AT2, AT3 and AT5. The solid line shows the best fit to a linear model, the 
dashed line shows the fit to a root-squared model, and the dotted line shows the 
fit to the two parameter model, incorporating both the linear and root-squared 
terms. 
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Figure S5.5 | The change in resistance profile through time of independent 
clones within population T4. Faceted by transfer clones were isolated from. The 
vertical line represents the concentration of tetracycline selected for during the 
evolution experiment. Points represent the mean of the three technical 
replicates with error bars showing SEM.  
 
Figure S5.6 | The change in resistance profile through time of independent 
clones within population AT2. Faceted by transfer clones were isolated from. 
The vertical line represents the concentration of tetracycline selected for during 
the evolution experiment. Points represent the mean of the three technical 
replicates with error bars showing SEM.  
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Figure S5.7 | The change in resistance profile through time of independent 
clones within population AT5. Faceted by transfer clones were isolated from. 
The vertical line represents the concentration of tetracycline selected for during 
the evolution experiment. Points represent the mean of the three technical 
replicates with error bars showing SEM.  
 
 
 
Figure S5.8 | Growth curves of the ancestral MG1655(RK2) and clones from 
transfers 8, 16, 40 and sequenced clones from transfer 80 from populations T4, 
AT2 and AT5 in the presence of tetracycline 10 µg/ml, the same concentration 
used in the selection experiment. Points are the mean of three replicates with 
error bars representing SEM. 
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Table S5.1 | ANOVA comparison of tetracycline resistance integrals with Tukey 
multiple comparison tests of A population T4, B population AT2, and C 
population AT5.  
 
A Population T4 
Factor d.f. Sum 
Squares 
Mean 
Squares 
F Value P 
Transfer 4 2.438 0.609    23.56 6.84e-09 
Residuals    30 0.776 0.026      
 
Comparison Difference P adjusted 
Anc – 8 -0.075 0.916 
Anc – 16 -0.647 0.0001 
Anc – 40 -0.464 0.0001 
Anc – 80 -0.631 0.0001 
8 – 16 -0.572 0.000 
8 – 40 -0.389 0.0001 
80 – 8 0.556 0.0001 
40 – 16 -0.183 0.138 
80 – 16 -0.017 0.999 
80 – 40 0.167 0.535 
 
B Population AT2 
Factor d.f. Sum 
Squares 
Mean 
Squares 
F Value P 
Transfer 4 0.982 0.245    11.1 1.21e-05 
Residuals    30 0.663 0.022   
 
Comparison Difference P adjusted 
Anc – 8 0.033 0.994 
Anc – 16 -0.274 0.019 
Anc – 40 -0.372 0.001 
Anc – 80 -0.179 0.482 
8 – 16 -0.308 0.001 
8 – 40 -0.405 0.000 
80 – 8 0.211 0.231 
40 – 16 0.097 0.639 
80 – 16 -0.096 0.868 
80 – 40 -0.193 0.315 
 
C Population AT5  
Factor d.f. Sum 
Squares 
Mean 
Squares 
F Value P 
Transfer 4 1.337   0.334 7.864 0.0002 
Residuals    30 1.274   0.042   
 
Comparison Difference P adjusted 
Anc – 8 -0.217 0.346 
Anc – 16 -0.379 0.020 
Anc – 40 -0.599 0.0001 
Anc – 80 -0.380 0.111 
8 – 16 -0.163 0.465 
8 – 40 -0.382 0.004 
80 – 8 0.164 0.756 
40 – 16 0.219 0.186 
80 – 16 0.001 1.000 
80 – 40 -0.218 0.515 
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Table S5.2 | ANOVA comparison of length of lag phase when growing in 
tetracyclin 10 µg/ml with Tukey multiple comparison tests of A population T4, B 
population AT2, and C population AT5. 
 
A Population T4 
Factor d.f. Sum 
Squares 
Mean 
Squares 
F Value P 
Transfer 4 59.53   14.882    18.23 2.71e-09 
Residuals    50 40.81    0.816     
 
Comparison Difference P adjusted 
Anc – 8 2.179 0.0002 
Anc – 16 3.339 0.000 
Anc – 40 3.392 0.000 
Anc – 80 3.796 0.000 
8 – 16 1.160 0.008 
8 – 40 1.213 0.005 
80 – 8 -1.617 0.009 
40 – 16 -0.053 0.999 
80 – 16 -0.457 0.863 
80 – 40 -0.404 0.908 
 
B Population AT2 
Factor d.f. Sum 
Squares 
Mean 
Squares 
F Value P 
Transfer 4 109.33   27.331    558.7 <2e-16 
Residuals    50 2.45    0.049   
 
Comparison Difference P adjusted 
Anc – 8 -0.246 0.214 
Anc – 16 2.776 0.000 
Anc – 40 2.759 0.000 
Anc – 80 2.583 0.000 
8 – 16 3.022 0.000 
8 – 40 3.005 0.000 
80 – 8 -2.829 0.000 
40 – 16 0.018 0.999 
80 – 16 0.193 0.448 
80 – 40 0.176 0.543 
 
C Population AT5  
Factor d.f. Sum 
Squares 
Mean 
Squares 
F Value P 
Transfer 4 110.03   27.507    25.17 1.86e-11 
Residuals    50 54.64    1.093     
 
Comparison Difference P adjusted 
Anc – 8 1.336 0.113 
Anc – 16 3.849 0.000 
Anc – 40 3.726 0.000 
Anc – 80 4.175 0.000 
8 – 16 2.513 0.000 
8 – 40 2.390 0.000 
80 – 8 -2.829 0.000 
40 – 16 0.123 0.998 
80 – 16 -0.316 0.977 
80 – 40 -0.439 0.925 
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Abbreviations 
 
AIC Akaike information criterion 
AMP Ampicillin 
AMR Antimicrobial Resistance 
ARG Antibiotic Resistance Gene 
bp Base Pair 
CFU Colony Forming Units 
CML Chloramphenicol 
DNA Deoxyribonucleic Acid 
ESBL Extending Spectrum β-lactamse 
GFP Green Fluorescent Protein 
HGT Horizontal Gene Transfer 
ICE Integrative and Conjugative Elements 
IS Insertion Sequence 
kb Kilobase 
Mb Mega-base 
MDR Multidrug Resistance 
MGE Mobile Genetic Element 
MIC Minimum Inhibitory Concentration 
MRSA Methicillin-Resistant Staphylococcus aureus 
MSC Minimum Selectable Concentration 
NB Nutrient Broth 
NDM New Delhi metallo-β-lactamase 
OD Optical Density 
PCR Polymerase Chain Reaction 
PK-PD Pharmacokinetic-Pharmacodynamic 
SEM Standard Error [of the] Mean 
SNP Single Nucleotide Polymorphism 
ssDNA Single Stranded Deoxyribonucleic Acid 
TA Toxin-Antitoxin 
TET Tetracycline 
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